Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Depressive Disorder

• A New Intervention to Improve Function in Veterans With Anxiety and Depression
• Feasibility of Conducting a Clinical Trial Assessing Efficacy of Lactate as Adjunctive Therapy in Patients With Major Depressive Disorder
• OptimizeD Pilot Study
• Evaluation of Psilocybin-Assisted Psychotherapy in Treating Severe Depression in Patients With PTSD
• ENA-001 for Post Operative Respiratory Depression (PORD)
• Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
• Psilocybin rTMS for Treatment Resistant Depression
• The Role of Negr1 In Modulating Neuroplasticity in Major Depression (RONIN)
• Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients
• Positioning of Esketamine Treatment in the Real-world Management of Depression
• Safety, Tolerability and Antidepressant Effects of DMT in Patients With Depression
• Ketamine for Combined Depression and Alcohol Use Disorder
• Effects of Acute Exercise and Ibuprofen on Symptoms, Immunity, and Neural Circuits in Bipolar Depression
• Dopaminergic Therapy for Anhedonia - 2
• Effect of Esketamine on Reducing Postoperative Anxiety and Depression in Adolescent Patients
• A Randomized Neuroimaging Trial of Psilocybin in Depression
• Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment
• PEA vs. Placebo for Major Depression
• Study to Assess the Effects of Oral NMRA-335140 in Participants With Major Depressive Disorder
• Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
• A Study of BRII-296 in Adults With Severe Postpartum Depression (PPD)
• Psychopharmacotherapy for Depressive Patients
• Study to Assess the Safety and Effectiveness of NMRA-335140-501
• Study to Evaluate the Effects of Oral NMRA 335140 Versus Placebo in Participants With Major Depressive Disorder
• Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain With Toludesvenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)
• Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD
• Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression
• Repeated Neurocognitive Measurements in Depressed Patients
• Identifying and Treating Depression in the Orthopaedic Trauma Population
• Study of ALTO-300 in MDD
• Dopamine Modulation of Motivation and Motor Function in Major Depression & Inflammation
• Ketamine Tolerated Dose to Prevent Postpartum Depression and Pain After Cesarean Delivery
• Assessing Dopamine Transporter Occupancy in the Healthy Adult Brain With Toludivenlafaxine Hydrochloride Extended-Release Tablets Using 11C-CFT Positron Emission Tomography (PET)
• 5-HTP and Creatine for Depression R33 Phase
• Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression
• BPL-003 Efficacy and Safety in Treatment Resistant Depression
• Synaptic Imaging and Network Activity in Treatment Resistant Depression
• Study of the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Participants With Tardive Dyskinesia
• Serotonin-norepinephrine Reuptake Inhibitor in Prophylaxis of Depression Following Fragility Fractures
• Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
• A Study of the Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Depression
• Inflammation and Depression in People With HIV
• Intradermal Acupuncture Versus Sham Acupuncture and SSRI for Treating Adolescents With Major Depressive Disorder
• Effects of Epidural Labor Analgesia With Esketamine on the Incidence of Postpartum Depression in Parturients
• Long-term Efficacy of Pramipexole in Anhedonic Depression
• Effect of Electroacupuncture on Treating the First-episode Depression
• Sequenced Treatment in Adolescents With Major Depression (STAMD): a Multicenter Open-label Randomized Controlled Trial
• Glutamate Emotion Memory Study
• Phase 2 Clinical Trial of GH001 in Postpartum Depression
• A Trial of GH001 in Patients With Treatment-resistant Depression
• Clinical Study to Evaluate the Possible Efficacy of Dapagliflozin and Atorvastatin in Patients With Major Depressive Disorders
• Clinical Study of Cang Ai Volatile Oil (CAVO) on Mild to Moderate Depression in Children and Adolescents
• Effect of Physiotherapy Protocol in Treatment of Depression: Longitudinal Study
• The Impact of AMPA Receptor Blockade on Ketamine's Anti-Suicidal Effects
• Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression
• Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine
• The Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression
• Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD)
• Open Label Extension Study of Depressed Mood Improvement Through Nicotine Dosing-3 (Depressed MIND3)
• Depressed Mood Improvement Through Nicotine Dosing 3
• A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Major Depressive Disorder With One Prior Treatment Failure
• D-Cycloserine+iTBS PK Study
• Influence of Oxycodone on Individuals Taking an SSRI
• Venlafaxine for the Prevention of Depression in Patients With Head and Neck Cancer
• The Effect of Probiotics on Depression Syndrome and Risk Factors of Cardiovascular Disease in Hemodialysis Patients
• The Efficacy and Cerebral Mechanism of Intradermal Acupuncture for Major Depressive Disorder
• Phase 2b Study of ALTO-100 in MDD
• N2O for Acute Suicidality and Depression in the ED
• Does Psilocybin Require Psychedelic Effects to Treat Depression?
• [18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET
• Effect of Low-dose Esketamine on Maternal Depression at 2 Years After Childbirth
• Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)
• Psilocybin for Major Depressive Disorder
• An Open-label, Adaptive Design, Positron Emission Tomography Study in Healthy Male Participants to Characterize Receptor Occupancy by MIJ821 in the Brain
• An Open-Label, Single Dose Study to Evaluate the Safety, Tolerability and Pharmacodynamics of BPL-003 in Patients With Treatment Resistant Depression
• Xanamem® in Adults With Major Depressive Disorder and Impaired Cognition (XanaCIDD)
• SAGE-217 Pharmacokinetics (PK) and Safety Study Pediatric Participants With Major Depressive Disorder (MDD)
• INflammation-based Stratification for Immune-Targeted Augmentation in Major Depressive Disorder
• IM and IV SPL026 Drug Product in Healthy Participants
• OSU6162 as add-on in SSRI/SNRI-resistant Depression
• Clinical Predictors of Intravenous Ketamine Response in Treatment-Resistant Depression
• Oral Aspirin + Ketamine as Adjunct to Oral Antidepressant Therapy for Depression
• Efficacy and Safety of Intradermal Acupuncture for Major Depressive Disorder
• Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
• PET Synaptogenesis After Psilocybin In DEpression Recovery
• A Study of Mianserin in Combination With SSRIs in Depression With Sleep Problems
• Multiple Ascending Dose and Electroencephalography Trial of GATE-202 in Healthy Volunteers
• Effect of SSRIs on Response to Psilocybin Therapy
• A Trial of the Safety and Efficacy of SEP-363856 in the Treatment of Adults With Major Depressive Disorder
• D-Cycloserine Augmentation of Intermittent Theta Burst Stimulation (iTBS) in Depression (COGENT)
• Electronic Training of Elderly Depression With Cognitive Impairment
• Is Brain Insulin Resistance a Feature of the Biology of Depression in Adolescents
• Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV
• Enoxolone in Major Depression - Biomarker-outcome Relationship
• VA Aripiprazole vs Esketamine for Treatment Resistant Depression
• SPL026 With or Without SSRIs in Participants With MDD
• A Study of Aticaprant 10 Milligrams (mg) as Adjunctive Therapy in Adult Participants With MDD With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy
• Defining Neurobiological Links Between Substance Use and Mental Illness
• SMART Trial to Predict Anhedonia Response to Antidepressant Treatment
• Trial of Centanafadine Efficacy and Safety as Monotherapy or as Adjunct to SSRI in Adults With Major Depressive Disorder
• RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)
• Multi-factor Model Constraction for Early Warning and Diagnosis of MDD
• Intradermal Acupuncture Based on Changes in Biological Specificity of Acupoints for Major Depressive Disorder
• A Study of Aticaprant in Adult and Elderly Participants With Major Depressive Disorder (MDD)
• An EEG Study of Intravenous Ketamine for Major Depression Disorder
• Open-label Brexpiprazole fMRI Trial in Adults With Major Depressive Disorder and Anxiety
• Personalized High-Definition Transcranial Direct Current Stimulation (HD-tDCS) Treatment for Major Depressive Episode
• GetHealthy-OA: A Program to Improve Pain and Function for Patients With Knee Osteoarthritis, Obesity, and Depression
• Vortioxetine Adjunctive Treatment in Bipolar Depression
• Chinese Longitudinal and Systematic Study of Bioplar Disorder
• Fluoxetine Treatment of Depression in Down Syndrome
• A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy
• Study of Efficacy, Safety, Tolerability and Pharmacokinetics of MIJ821 in Participants With Treatment- Resistant Depression (TRD)
• Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression
• ANC-501 in the Treatment of Adults With Major Depressive Disorder
• Repeated Intranasal Esketamine Plus Almond Therapy in Participants With Treatment Resistant Depressive Disorder - 3 Month Extension Study
• Rapid Improvement of Depression of Fluoxetine Combined With ATP or Phosphocreatine
• Measurement-Based Care Vs. Standard Care for Major Depressive Disorder
• Anti-suicidal Effects of Buprenorphine In Depressed Individuals
• Prophylactic Effects of Agomelatine for Poststroke Depression
• ALTO-100 in Major Depressive Disorder
• Single Dose Oral Bioequivalence Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets
• Assessing SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide
• Food Effect Bioavailability Study of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets
• Single Dose Study to Evaluate Dose-proportionality of Vortioxetine Hemihydrobromide Orally Disintegrating Tablets
• Treating Immuno-metabolic Depression With Anti-inflammatory Drugs
• Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder
• Study on the Optimal Diagnosis and Treatment Strategy of Major Depressive Disorder Based on Anhedonia
• A Study of a Psilocybin Analog (CYB003) in Participants With Major Depressive Disorder
• Psilocybin Versus Ketamine in Treatment-Resistant Depression
• The Effects of Psilocybin on Self-Focus and Self-Related Processing in Treatment Resistant MDD
• A Study to Evaluate the Safety, Tolerability and Efficacy of XEN1101 in Major Depressive Disorder
• A Multicenter Clinical Study on Shuganjieyu Capsule Combined With Fluoxetine in the Treatment of Depression
• Antidepressant Effects of Nitrous Oxide
• Pramipexole for Anhedonic Depression
• Acupuncture Therapy Based on Biological Specificity of Acupoints for Major Depressive Disorder
• Intradermal Needle Therapy for Major Depressive Disorder
• Effects of a Single Dose of Amisulpride on Functional Brain Changes
• Maintenance Ketamine Infusions for Treatment-Resistant Bipolar Depression
• Reversal of Opioid-induced Respiratory Depression With Opioid Antagonists
• Study on Allopregnanolone and Depression in Perimenopausal Women
• Glutamatergic Adaptation to Stress as a Mechanism for Anhedonia and Treatment Response With Ketamine
• Pentoxifylline for Treatment of Resistant Major Depression
• Repeated Intranasal Esketamine Plus Almond Therapy in Patients With Treatment Resistant Depression
• The Effect of Ketamine on Aesthetics and Role for Antidepressant Effects
• Effects of Ghrelin Administration on Dopamine and Effort
• Prevention of Postpartum Depression: A Pilot Placebo-controlled Trial of Trazodone
• OSU6162 in Bipolar Depression (OBID)
• Predictors of Cognitive Outcomes in Geriatric Depression
• Pentoxifylline as an Adjunct to Citalopram in Adult Patients With Major Depressive Disorder
• A Study to Assess Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy (CBT) in Conjunction With Esketamine in Participants With Treatment-resistant Depression
• Effects of Ciprofol Anesthesia on Learning and Memory Function and Antidepressant Effects of ECT in Depressive Patients
• Microdosing Psychedelics to Improve Mood
• Clinical Effectiveness of Choline Alphoscerate for Older Adults With Major Depression and Subjective Memory Complaints
• A Clinical Study on the Effects of Inhalation of Volatile Oil of Cang-Ai Via the Nose on Patients With Depression
• Assessing the Safety and Efficacy of MYMD1 to Treat Depression in Patients With Post-Acute Sequelae of Coronavirus Disease-2019 (PASC)
• Influence of Δ9-tetrahydrocannabinol (THC) on Oxycodone Induced Ventilatory Depression in Healthy Volunteers
• Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.1. (Pharmacological Manipulation)
• Effects of Esketamine on Postpartum Depression
• Psilocybin-assisted CBT for Depression
• This is a Clinical Trial to Determine the Long-term Safety and Tolerability of an Investigational Drug in People With Major Depressive Espisode Associated With Bipolar I Disorder (Bioplar I Depression).
• The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation
• Prucalopride and Cognition in Recovered Depression
• RESET-medication Glucocorticoid Receptor (GR) Blockade as Disease Modifying Treatment for Depression With Childhood Trauma
• Low-Dose Intravenous Ketamine for Adolescents With Depression and Suicidal Ideation in the Emergency Department
• The Pill Project - Oral Contraceptive and Serotonergic Brain Signaling
• A Study of SDI-118 in Participants in Remission From Depression
• Study to Assess the Efficacy and Safety of Adjunctive NBI-1065845 in Adults With Major Depressive Disorder (MDD)
• A Study To Evaluate The Safety, Tolerability And Pharmacokinetics of HS-10345 In Treatment-Resistant Depression
• A Study of HS-10353 in Chinese Participants.
• KAP for Depression in Abstinent Opioid Users
• Repurposing of Dextromethorphan as an Adjunct Therapy in Patients With Major Depressive Disorder
• A Clinical Study of an Investigational Drug for the Treatment of Major Depressive Episode Associated With Bipolar I Disorder.
• Ketamine + Mindfulness for Depression
• Study to Evaluate the Efficacy and Safety of Once-Weekly Oral NBI-1065846 in the Treatment of Anhedonia in MDD
• ALTO-300 in Depression (ALTO-300-004)
• Intravenous Esketamine on Prevention of Postoperative Depression in Patients Undergoing Cardiac Surgery
• A Pilot Study on Effect of add-on Sulforaphane to SSRIs and Application of Niacin Skin Flush Response Test in Major Depressive Disorder
• A Comparative Study on Efficacy and Safety of add-on Sulforaphane or rTMS to Escitalopram for Major Depressive Disorder With Poor Response to Initial Treatment
• A Single and Multiple Ascending Dose Trial of CVL-354 in Healthy Participants
• Intranasal Ketamine in Ultra-REsistant Depression (SURE-ECT Non Responders)
• NMDA Modulation in Antidepressant Nonresponders With Major Depressive Disorder
• A Study of Xiongdan Wan Treating Depression
• Clinical Study on the Safety and Efficacy of Dental Pulp Mesenchymal Cells in the Treatment of Depression
• A First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of DGX-001
• ALTO-300 in Depression
• IMPase in Treatment-resistant Depression
• ALTO-100 in MDD and/or PTSD
• A Randomized, Double-Blind, Placebo-Controlled Study of Liafensine in Patients With Treatment-Resistant Depression
• Vortioxetine as a Novel Anti-depressant With Improvement in Cognitive Abilities
• A Study to Assess the Efficacy and Safety of REL-1017 as Monotherapy for Major Depressive Disorder (MDD)
• Phase 2 Study of NV-5138 in Adults With Treatment Resistant Depression
• An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
• Multicenter Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
• Dopamine D3 Receptor Occupancy in Bipolar Depression
• Ketamine for OUD and Comorbid Depression (OUDCD)
• The Role of Neuromodulation Technique In Depression Disorder
• Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel Therapeutic Targets
• Low-dose Ketamine Infusion Among Adolescents With Treatment-resistant Depression
• Cannabinoids as a Treatment for Insomnia in Major Depression
• The Phosphodiesterase 5 Inhibitor Tadalafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients
• Psilocybin for Treatment-Resistant Depression
• Effectiveness of Ketamine Treatment for Three Consecutive Days in Depression
• Study of Ammoxetine Hydrochloride Enteric-coated Tablets in Subjects With Depression
• Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D)
• Vortioxetine to Prevent Return of Symptoms in Children With Depression
• Sevoflurane for Treatment-Resistant Depression
• Nitrous Oxide for Late-Life Depression - PROTO-BRAIN
• Aβ Dynamics in LLMD
• Treatment Interrupts Depression Early
• A Comparison of Two Psychotherapy Programs in Persistently Depressed Treatment-Resistant Inpatients
• Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults
• Clinical Trial of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
• The Efficacy And Safety Of Mitizodone Phosphate Tablets In The Treatment of Patient With Major Depressive Disorder
• Research on Risk Factors and Interventions of Polycystic Ovary Syndrome Complicated With Depression and Anxiety
• Safety and Tolerability of GATE-251 in Normal Human Volunteers
• Targeting IL-17A for Treatment-Resistant Depression
• Glutamate and Opioid Mechanisms of Antidepressant Response to Ketamine
• Mood Disorders in Head and Neck Cancer Patients
• Safety of Liposom With Citalopram in Elderly Patients With Major Depressive Disorder
• Evaluation of Efficacy and Safety of add-on Sarcosine in Patients With Major Depressive Disorder
• Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer
• An Evaluation of AXS-05 for the Treatment of TRD in Treatment-Adherent Patients
• A Clinical Trial of Adjunctive PRAX-114 in Participants With Major Depressive Disorder
• Sustained Mood Improvement With Laughing Gas Exposure: A Randomized Controlled Pilot Trial
• A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adolescents With Major Depressive Disorder Who Have an Inadequate Response to Selective Serotonin Reuptake Inhibitor (SSRI) and Psychotherapy
• The Safety, Tolerability, and Effectiveness of Quetiapine in Postpartum Depression
• Ketamine for the Treatment of Depression in Parkinson's Disease
• Ketamine as an Adjunctive Therapy for Major Depression (2)
• A Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Depression Who Take Anti-depressive Medication
• Comparison of Antidepressant Augmentation With Amantadine vs Pramipexole vs Quetiapine in Treatment Resistant Depression
• Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease
• ECT vs. Esketamine
• Repeated Neurocognitive Measurements in Depressed Patients
• Low Dose Amisulpride Vs Olanzapine-Fluoxetine Combination in Post-Schizophrenic Depression
• Use of Transmucosal Ketamine in Post Stroke Depression
• Esketamine on Postpartum Depression in Cesarean Section Women
• Open Label Study to Assess the Safety of REL-1017 for Major Depressive Disorder
• A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD)
• A Study to Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)
• Effect of Low-dose Esketamine on Postoperative Depression in Patients With Breast Cancer
• Reward Emotion Learning and Ketamine Study
• Esketamine Adjuvant Therapy for Patients With Chronic Visceral Pain Comorbid Major Depressive Disorder
• Effects of Intravenous (IV) Citalopram Hydrochloride During Transcranial Magnetic Stimulation in Major Depressive Disorder (MDD)
• Add-on Therapy With Edupression.Com® on Therapy Resistant Depressive Patients Treated With Nasal Esketamine Spray
• Enhancing Processing Speed and Executive Functioning in Depressed Older Adults With Computerized Cognitive Training
• A Clinical Trial of PRAX-114 in Participants With Major Depressive Disorder
• Brexpiprazole as Adjunctive Therapy in Adults With Major Depressive Disorder
• A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray Treatment
• Clonidine to Prevent Delirium After Electroconvulsive Therapy.
• XEN1101 for Major Depressive Disorder
• Efficacy and Safety of Peropirone Hydrochloride Tablets in the Treatment of Adolescent Bipolar Disorder Depression
• Antidepressant Effects of TS-161 in Treatment-Resistant Depression
• The Effect of Celecoxib on Neuroinflammation in MDD
• TDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemic
• A Study of the Change in Disease State and Safety of Oral Cariprazine Capsules in the Treatment of Depression in Pediatric Participants (10 to 17 Years of Age) With Bipolar I Disorder
• Integrating a Stepped Care Model of Screening and Treatment for Depression Into Malawi's National HIV Care Delivery Platform
• Post-stroke Depression Treatment Effect on Stroke Recurrence
• The Phosphodiesterase 4 Inhibitor Roflumilast as an Adjunct to Antidepressants in Major Depressive Disorder Patients
• The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression
• Cannabidiol for Treatment Resistant Depression
• Stellate Ganglion Block for Major Depressive Disorder.
• ANTIVIRAL TREATMENT OF CYTOMEGALOVIRUS IN DEPRESSION
• DTA (Dopaminergic Therapy for Anhedonia) Study
• Study of Efficacy and Safety of MIJ821 in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicidal Ideation With Intent
• The Modulatory Role of Communicated Treatment Rationale on Treatment Expectation Effects in Depression.
• Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans
• Phase 1 Evaluation of (2R,6R)-Hydroxynorketamine
• Clinical Study of GH001 in Depression
• Antidepressant Response in Older Adults With Comorbid PTSD and MDD
• A Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment for Major Depressive Disorder (MDD)
• Maternal Mental Health Trial
• Slow Wave Induction by Propofol to Eliminate Depression (SWIPED) - Phase I
• SPL026 (DMT Fumarate) in Healthy Subjects and MDD Patients
• Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression
• A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of Suicide
• Efficacy and Safety of MK-1942 When Added to Stable Antidepressant Therapy in Participants With Treatment-Resistant Depression (TRD) (MK-1942-006)
• Dexmedetomidine Adjuvant Treatment for Depressed Patients Undergoing ECT
• Levodopa and Exercise for Older Adults With Depression and Psychomotor Slowing
• LTP+CaCBT for Treating Postnatal Depression and Improving Child Wellbeing in Jos Nigeria
• IM Ketamine vs Midazolam for Suicidal ER Patients
• NMDA Modulation in Major Depressive Disorder
• Open-Label Safety Study of AXS-05 in Subjects With TRD
• The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density
• the Safety, Tolerability, and Pharmacokinetics Study of HEC113995
• Evaluation of the Safety and Pharmacokinetics of MSI-195 to a Commercial S-Adenosylmethionine
• Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder
• Safety and Tolerability of Single and Multiple Ascending Doses of GATE-101 in Normal Human Volunteers
• Defining and Treating Depression-related Asthma
• Mechanistic Evaluation of Response in TRD (MERIT)
• The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depression
• A Study of Esketamine Nasal Spray, Administered as Monotherapy, in Adult Participants With Treatment-resistant Depression
• Tolerability and Pharmacokinetics of Hypidone Hydrochloride in Healthy Subjects
• The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder
• The Safety, Tolerability, and Pharmacokinetics Study of HEC113995 PA•H2O Tablets in Healthy Subjects
• Agomelatine Augmentation Added to SSRIs or SNRIs for Depression
• Imaging Neural Correlates of Ketamine Using PET/MR
• PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
• Brexpiprazole Treatment for Bipolar I Depression
• Effect of Self-administered tDCS in Patients With MDD
• A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With S
• A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
• PKC as Serum Biomarkers for Depression
• The Efficacy and Safety of Ginkgo Biloba Dropping Pills in the Treatment of Coronary Heart Disease With Stable Angina Pectoris and Depression
• Optimization of Diagnosis and Treatment of Depression Based on Multidimensional Clinical Assessment Classification
• A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression
• A Study of Seltorexant Compared to Quetiapine XR as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant Therapy
• Bear Bile Pill as add-on the Treatment of MDD
• Psychostimulant Augmentation of Repetitive TMS for the Treatment of Major Depressive Disorder
• A Pilot Study of Creatine Monohydrate as an Augmenting Agent for ECT in Persons With Major Depressive Disorder
• Ketamine for Older Adults Pilot
• Vortioxetine for Treatment of Depressive Mood and Alcohol Use
• 1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)
• Effect of Zinc Supplementation on Depression in SSRI-treated Major Depressive Disorder Patients
• A Study of the Safety and Efficacy of SP-624 in the Treatment of Adults With Major Depressive Disorder
• An Expanded Access Protocol for Esketamine Treatment in Participants With Treatment Resistant Depression (TRD) Who do Not Have Other Treatment Alternatives
• A Comparative Study of Sage-217 Plus an Antidepressant (ADT) Versus Placebo Plus an ADT in Adults With Major Depressive Disorder
• Ketamine or Placebo in Patients With Major Depression and Advanced Cancer
• Dopaminergic Dysfunction in Late-Life Depression
• A Study of Oral Seltorexant as an add-on Medication to an Antidepressant on On-road Driving Performance in Participants With Major Depressive Disorder
• Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From Depression
• A Study to Evaluate the Efficacy and Safety of SAGE-217 in Participants With Severe Postpartum Depression (PPD)
• A Study to Evaluate the Efficacy of Sage-217 in the Treatment of Adult Participants With Major Depressive Disorder (MDD)
• eIMPACT-DM Pilot Trial: Depression Treatment to Reduce Diabetes Risk
• An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)
• The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.
• Depressed Mood Improvement Through Nicotine Dosing 2
• Candesartan as an Adjunctive Treatment for Bipolar Depression
• Brain Hippocampal Volume Relationship With Anxious Symptoms in Major Depressive Patients
• A Home-based Study Using Mobile Technology to Test Whether BI 1358894 is Effective in People With Depression
• Combination of Novel Therapies for CKD Comorbid Depression
• Treatment of Bipolar Depression With Pentoxifylline
• Low-dose S-ketamine in Women With Prenatal Depression
• The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients
• Buspirone and Melatonin for Depression Following Traumatic Brain Injury
• The Effect of S-ketamine for Patients Undergoing Electroconvulsive Therapy (ECT)
• 5-HTP and Creatine for Depression
• Leveraging EEG for Antidepressant Prediction With Sertraline and Escitalopram
• Leveraging EEG for Antidepressant Prediction With Duloxetine and Bupropion
• A Study of Lurasidone Compared With Placebo for the Treatment of Bipolar I Depression
• Study of Desvenlafaxine in Treating Major Depressive Disorder.
• Study to Assess the Effects of Intranasal Ketamine Along With rTMS for Patients With Treatment-resistant Major Depressive Disorder (TRD)
• Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits
• A Study of MD-120 in Patients With Depression
• The Phosphodiesterase 5 Inhibitor Sildenafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients
• A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depres
• Study of Naltrexone-Induced Blockade of Antidepressant Effects
• Treatment for Cognitive Impairment in Depression
• Study to Learn About Relapse Prevention of Hypericumextract (a Drug Based on the Plant St. John Wort) in Outpatients Suffering From Moderate Depressive Episodes
• Does rTMS Induce Synaptic Plasticity?
• Theophylline for Depression Study
• Effect of Esketamine on Postoperative Depression、Gut Microbiota、Bispectral Index Data of Depression Patients Undergoing Breast Cancer Operation (ESPOD-BI)
• Pupillary Unrest in Ambient Light, and Relationship to Opioid-Induced Respiratory Depression
• Tolerability, Safety and Efficacy of Vortioxetine
• Simvastatin add-on Treatment to Standard Antidepressant Therapy in Patients With Comorbid Obesity and Major Depression
• Vortioxetine in Patients With Depression and Early Dementia
• Open-label, Flexible-dose Study of Vortioxetine in Patients With Depression in India
• Clinical Trial Evaluating Lumateperone Monotherapy in the Treatment of Bipolar Depression or Major Depressive Disorder
• Rapid Antidepressant Improvement Secondary to Excitatory Brain Responses
• A Study to Evaluate Multimodal Neuroimaging Parameters in Women With Postpartum Depression Who Are Receiving ZULRESSO™ (Brexanolone)
• The Activation on Prefrontal Cortex With Acupuncture and Moxibustion for Major Depressive Disorder: A Study of Functional Near Infrared Spectroscopy
• Effectiveness of Ketamine for Depression and Suicidal Ideation in the Emergency Department
• Tianeptine for Treatment Resistant Depression
• A 12-weeks Study to Evaluate Sulforaphane in the Treatment of Depression
• Determining Optimal Treatment Sequences in Anxious Depression (DOTS-AD)
• A Phase 2 Trial of OPC-64005 for Major Depressive Disorder
• 8 Week Multi-site Study of MYDAYIS® for Bipolar Depression
• Intramuscular Ketamine Versus Aripiprazole and Escitalopram in the Treatment of Resistant Depression
• Ketamine to Prevent PPD After Cesarean
• Three Dosing Regimens of Dextromethorphan (DXM) Reportedly Used in Major Depressive Disorder
• Study in Major Depressive Disorder With BTRX-335140 vs Placebo
• Preoperative Ketamine and Perioperative Depression
• Biomarkers of Response to Ketamine in Depression: MRI and Blood Assays Before and After Open Label Intranasal Ketamine
• Scopolamine in Bipolar Depression
• Comparison of Anyu Peibo With Placebo in Treatment of MDD in China
• A Study of Individualized Diagnosis and Treatment for Major Depressive Disorder With Atypical Features
• Accurate Clinical Study of Medication in Patients With Depression Via Pharmacogenomics (PGx) and Therapeutic Drug Monitoring (TDM) of Venlafaxine
• Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode
• Brain Reactivity to Nitrous Oxyde in Depression : an MRI and Ultrasound Study (PROTOBRAIN Pilote)
• The BIomarker Guided Study for Depression
• Comparison of the Efficacy, Safety, and Relapse of ECT to ECT Plus Agomelatine for Depressed Patients
• Ketamine for the Treatment of Opioid Use Disorder and Depression
• Efficacy of Deep Anaesthesia With Isoflurane as a Fast-response Antidepressant Agent
• Citalopram and Self Emotional Processing
• Canadian Biomarker Integration Network for Depression (CAN-BIND) - Validation Study
• Citalopram and Stress Reactivity
• A Clinical Trial of Fluvoxamine for Melancholia
• The Role of PKC Activation in the Immune-inflammatory Mechanism of Major Depressive Depression
• Epinephrine and Cortisol in Depression
• Tofacitinib in Depression (TIDE)
• Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
• Pramipexole to Target "Anhedonic Depression"
• Antidepressant Trial With P2X7 Antagonist JNJ-54175446
• Opiate Suicide Study in Patients With Major Depression
• Exercise Plus Duloxetine for Knee Osteoarthritis and Depression
• CLE-100 as an Oral Therapy in Addition to Standard Antidepressant Drug for Major Depressive Disorder - CLEO Study
• Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality
• Ketamine for Mood Disorders With Suicidal Ideation
• A Pilot Trial of Perinatal Depression Treatment in HIV Infected Women
• Ketamine Treatment Effects on Synaptic Plasticity in Depression
• The Antidiabetic Metformin as a Novel Adjunct to Antidepressants in Major Depressive Disorder Patients
• Ketamine Interleaved With Electroconvulsive Therapy for Depression
• Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder.
• A Study of JNJ-61393215 in the Treatment of Depression
• Neurofeedback In Treatment Resistant Depression
• The Phosphodiesterase-3 Inhibitor Cilostazol as an Adjunctive to Antidepressants in Patients With Major Depressive Disorder.
• Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model
• A Study to Evaluate the Efficacy and Safety of Fremanezumab for Preventive Treatment of Migraine in Patients With Major Depressive Disorder
• Open-Label Safety Study of AXS-05 in Subjects With Depression
• Clinical Study of Escitalopram Oxalate Combined With taVNS in Depression and Concomitant Inflammatory Symptoms
• Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans
• Ketamine for Treatment Resistant MDD
• A Trial of AXS-05 in Patients With Major Depressive Disorder
• Effects of Escitalopram on the Sleep EEG Power in Patients With Major Depressive Disorder
• Efficacy And Tolerability Of Sub-Anesthetic Ketamine In Postpartum Depression
• A Study to Evaluate SAGE-217 for Prevention of Relapse in Adult Subjects With Major Depressive Disorder
• FEcal Microbiota Transplantation
• Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment
• Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment (CLARITY-2)
• Promoting Enhanced Pharmacotherapy Choice Through Immunomarkers Evaluation in Depression
• Vortioxetine vs Sertraline in Mexicans
• The Role of HNKs in the Antidepressant Effect of Ketamine
• the Efficacy and Safety of Agomelatine in the Patients With Parkinson's Disease
• Mechanism of Action Underlying Ketamine's Antidepressant Effects: The AMPA Throughput Theory in Patients With Treatment-Resistant Major Depression
• Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment (CLARITY-2)
• Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Bipolar Depression
• Efficacy, Safety and Pharmacokinetic Study of Inhaled Esketamine in Treatment-resistant Depression
• Minocycline as Adjunctive Treatment for Treatment Resistant Depression
• Adjunctive D-Cycloserine in Major Depressive Disorder
• Nitrous Oxide for Major Depressive Disorder
• Low-dose S-Ketamine and Postpartum Depression in Parturients With Prenatal Depression
• Brain Insulin Resistance in Mood Disorders
• Treating Depression With Transcutaneous Electrical Cranial-auricular Acupoint Stimulation (TECAS).
• Citalopram Titration in Early Non-responder Patients With Major Depressive Disorders
• Study on the Effect of PRKCB1 Modulating Inflammatory Factors and the Role for Developing Major Depressive Disorder
• Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy
• Investigate the Clinical Responses of Ethosuximide in Patients With Treatment-Resistant Depression.
• Scopolamine in Healthy Volunteers
• Nitrous Oxide for the Treatment of Major Depressive Disorder
• LSD Therapy for Persons Suffering From Major Depression
• A Study of Psilocybin for Major Depressive Disorder (MDD)
• A Study to Evaluate SAGE-217 in Adult Participants With Major Depressive Disorder (MDD)
• Effects of Acute Prucalopride Administration in Healthy Volunteers
• Intraoperative Ketamine Versus Saline in Depressed Patients Undergoing Anesthesia for Non-cardiac Surgery
• Study of Rapastinel as Monotherapy in Major Depressive Disorder (MDD)
• A Study in People With Depression to Test the Effects of BI 1358894 on Parts of the Brain That Are Involved in Emotions
• A Study of Esketamine Nasal Spray Plus a New Standard-of-care Oral Antidepressant or Placebo Nasal Spray Plus a New Standard-of-care Oral Antidepressant in Adult and Elderly Participants With Treatment-resistant Depression
• The Recovery of Cardiovascular Patients With Depression
• Study With Vortioxetine on Emotional Functioning in Patients With Depression
• A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients
• Glabellar Botulinum Toxin Injections for the Treatment of Geriatric Depression
• Poststroke Depression in Hemorrhagic Stroke
• Treating Smokers With Mental Illness
• A Relative Bioavailability Food Effect Study of LY03005
• Contact: Developing New Clinical Management Strategies
• Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia Individuals
• Mild-Intensity Whole Body Hyperthermia (WBH) for Major Depressive Disorder
• Dose-Finding Clinical Trial to Evaluate the Efficacy and Safety of LY03005 Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)
• Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic Assessment
• The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression
• A Study to Evaluate the Safety, Tolerability, and Efficacy of SAGE-217 Compared to Placebo in Adult Subjects With Comorbid Major Depressive Disorder and Insomnia
• Vortioxetine Intravenous Infusion at Initiation of Oral Treatment With Vortioxetine in Patients With Depression
• L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults
• Proof of Concept Study Evaluating the Efficacy and Safety of MIJ821 in Patients With Treatment-resistant Depression
• Xenon Inhalation Therapy for Major Depressive Disorder and Bipolar Disorder
• Evaluation of Schemes of Administration of Intravenous Ketamine in Depression
• Effects of a Tissue Selective Estrogen Complex (TSEC) on Depression and the Neural Reward System in the Perimenopause"
• Study to Explore the Effective Doses and to Assess the Safety and Efficacy of Hypidone Hydrochloride Tablets
• The Object of This Study is to Evaluate the Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepre
• Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone
• A Long-Term Study of Brexpiprazole in Patients With Major Depressive Disorder
• Nitrous Oxide- Suicidal Ideation
• A Study of LY03005 vs Pristiq
• Brain Imaging to Understand the Role of Inflammation in N-Acetyl Cysteine (NAC) Treatment of Bipolar Depression
• AGN-241751 in the Treatment of Major Depressive Disorder
• Ketamine for Major Depressive Disorder
• Clinical, Neurocognitive, and Emotional Effects of Psilocybin in Depressed Patients - Proof of Concept
• A Study of Brexpiprazole in Patients With Major Depressive Disorder
• A Study to Evaluate SAGE-217 in Subjects With Bipolar I/II Disorder With a Current Major Depressive Episode - Part A
• Effects of an ER Beta Agonist (Lilly Compound LY500307) on Estradiol-Withdrawal-Induced Mood Symptoms in Women With Past Perimenopausal Depression
• Study of Rapastinel as Monotherapy in Patients With Major Depressive Disorder (MDD)
• Ketamine Versus Electroconvulsive Therapy in Depression
• A Study to Evaluate the Efficacy of SAGE-217 in the Treatment of Adult Subjects With Major Depressive Disorder
• Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD)
• A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD)
• Bioavailability Study of Amitriptyline Hydrochloride Tablets
• Add-on Buprenorphine at Analgesic Doses for the Treatment of Severe Suicidal Ideas During a Major Depressive Episode
• Development of Pregnenolone as a Treatment for Depression R61
• A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
• A Study in Patients With Major Depressive Disorder
• A Prediction Study of Multiple Indexes of the Effect of Different Mechanisms of Antidepressants Treatment on Depression
• Modafinil's Effects on Cognition in Remitted MDD
• Study of Monotherapy Rapastinel in the Prevention of Relapse in Patients With Major Depressive Disorder (MDD)
• A Long Term Study of ALKS 5461 in the Treatment of Refractory Major Depressive Disorder (MDD)
• A Multimodal Neuroimaging Study of Brain Activation Patterns Under Ketamine
• Auricular Concha Electro-acupuncture for the Treatment of Depression
• Safety, Tolerability, PK and Efficacy of Single Doses of NV-5138 in Healthy Volunteers and Subjects With Treatment-Resistant Depression
• Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
• Vortioxetine add-on Treatment Improves the Symptoms in Patients With Bipolar Depression
• Assessing Symptomatic Clinical Episodes in Depression
• AGN-241751 in the Treatment of Major Depressive Disorder
• Vortioxetine Monotherapy for Major Depressive Disorder in Type 2 Diabetes
• Ketamine Associated ACC GABA and Glutamate Change and Depression Remission:
• Effects of Seven Day Prucalopride Administration in Healthy Volunteers
• Efficacy, Safety, and Tolerability of Levomilnacipran ER in Pediatric (7-17 Years) With Major Depressive Disorder
• Comparison of Two Forms of Oxcarbazepine for the Treatment of Bipolar Depression
• Study of Rapastinel as Monotherapy in Patients With MDD
• A Study to Explore the Efficacy of JNJ-67953964 in the Treatment of Depression
• The Study of Mindfulness-based Cognitive Therapy and Major Depressive Disorder
• Role of Pentoxifylline as an Adjuvant Therapy for Adult Patients With Major Depressive Disorder
• Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder
• Effect of Food, Gender, and Age on the Pharmacokinetic Profile of SUVN-911 in Healthy Subjects
• Pharmacogenetics Informed Tricyclic Antidepressant Dosing (PITA)
• A Clinical Study to Test the Effectiveness of an Investigational Drug to Treat People That Have Major Depressive Episodes When They Have Bipolar 1 Depression
• Trial of the Rapid Antisuicidal Effects of Intranasal Ketamine in Comorbid Depression and Alcohol Abuse
• A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder
• Combinatorial Pharmacogenomics Testing in Treatment-Naïve Major Depressive Disorder
• Anxiety and Depression in Epilepsy: A Pilot Treatment Study
• PF-04995274 and Emotional Processing in Un-medicated Depression
• PF-04995274 and Emotional Processing in Treatment Resistant Depression
• Cycloserine rTMS Plasticity Augmentation in Depression
• A Neurosteroid Intervention for Menopausal and Perimenopausal Depression
• Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers
• The Study About Mechanism of Transcranial Magnetic Stimulation Treatment of Depression Using Medical Imaging
• Effects of the Addition of Metyrapone to Antidepressant Therapy in Depression With Dexamethasone Suppression Test Non-suppression.
• Zaleplon in HIV Patients With Depression
• The Safety and Efficacy of Brexpiprazole as Adjunctive Therapy in the Treatment of Major Depressive Disorder
• Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression
• SMART-DAPPER: Leveraging the Depression And Primary-care Partnership for Effectiveness-implementation Research Project
• Anxiety and Depression in Epilepsy: A Treatment Study
• A Clinical Trial of Oral Ganaxolone in Women With Postpartum Depression
• A Study to Evaluate the Efficacy and Safety of MIN-117 in Adult Patients With Major Depressive Disorder
• OxSYPan: Oxford Study With Young People on Antidepressants
• Single-dose Ketamine for the Reduction of Pain and Depression in the Emergency Department
• Simvastatin as an Augmentation Treatment for Treatment Resistant Depression: Randomized Controlled Trial.
• A Study to Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
• Creatine Monohydrate Use for Preventing Altitude Induced Depression
• Pathophysiology of Neurodegeneration in Late-life Depression (AV45+THK)
• Psilocybin vs Escitalopram for Major Depressive Disorder: Comparative Mechanisms
• Brexpiprazole for Bipolar Depression
• A Study of Abilify® Tablet(Aripiprazole) as an Adjunctive Treatment in the Bipolar Depression
• NMDA Modulation in Major Depressive Disorder in Late- Life
• Study of Ketamine for Depression in Cancer Patients Receiving Palliative Care
• To Explore the Safety and Efficacy of Hypidone Hydrochloride Tablets in Treatment of Patients With MDD
• NRX101 Glx Biomarker Validation Study
• NRX101 Glx Biomarker Validation Study
• NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression
• NRX-101 for Maintenance of Remission From Severe Bipolar Depression in Patients With Suicidal Ideation
• NRX101 for Moderate Bipolar Depression and Suicidal Ideation
• A Study of Duloxetine (LY248686) in the Treatment of Japanese Children and Adolescents With Depressive Disorder
• Identifying and Treating Depression in Hemodialysis Patients
• Adherence to Antidepressant Treatment in Subjects With Depression
• The Safety and Efficacy of Naltrexone and Scopolamine Utilized in the Treatment of Major Depression
• Efficacy of Resveratrol in Depression
• Psilocybin and Depression
• Metformin, Vitamin D, and Depression in Polycystic Ovary Syndrome (PCOS) Trial
• A Study to Investigate the Antidepressant Mechanism-of-action of JNJ-42847922 in Participants With Major Depressive Disorder
• Alpha-Amino-3-Hydroxy-5-Methyl-4- Isoxazole Propionic Acid Receptor Components of the Anti-Depressant Ketamine Response
• Relative Bioavailability (RBA) Study of LY03005 vs Pristiq®
• A Study of Rapastinel for Rapid Treatment of Depression and Suicidality in Major Depressive Disorder
• Effects of Erythropoietin for Cognitive Side-effects of ECT
• Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal Depression
• Simplified Cognitive Behavioral Therapy for Generalized Anxiety Disorder and Depression
• Chinese Herb for the Treatment of Depression and Anxiety Disorders
• A Study to Compare the Efficacy, Safety, and Tolerability of JNJ-42847922 Versus Quetiapine Extended-Release as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepress
• Treating Hearing Loss to Improve Mood and Cognition in Older Adults
• Effects of Erythropoietin on Cognition and Neural Activity in Mood Disorders
• A Study of Duloxetine (LY248686) in Japanese Children and Adolescents With Depressive Disorder
• Efficacy and Safety of TAK-653 in Treatment-Resistant Depression
• Cannabidiol as an Adjunctive Treatment for Bipolar Depression
• Effect of Lithium Versus Placebo in Adults With Treatment-Resistant Depression Who Are Receiving Ketamine
• Clinical Trial Scheme of Shu Gan yi Yang Capsule
• Stepped Care aiTBS 2 Depression Study (Ghent)
• Inhaled Nitrous Oxide for Treatment-Resistant Depression: Optimizing Dosing Strategies
• Comprehensive Acupuncture for Depressive Disorder With Comorbid Psychogenic Pain
• Fecal Microbiota Transplantation in Depression
• Add-on to Cognitive, Event-Related Potentials (ERP) and Electroencephalogram (EEG) Asymmetry in Affective Disorders
• Effects of Probiotics on Symptoms of Depression
• ECT With Ketamine Anesthesia vs High Intensity Ketamine With ECT Rescue for Treatment-Resistant Depression
• Allogeneic HUman Mesenchymal Stem Cell InfusioN Versus Placebo in Subjects With Alcohol Use Disorder and Major DepreSsion.
• Ketamine as an Adjunctive Therapy for Major Depression
• Lumateperone Monotherapy for the Treatment of Bipolar Depression Conducted Globally
• Intravenous Ketamine Plus Neurocognitive Training for Depression
• A Clinical Trial of Intravenous Ganaxolone in Women With Postpartum Depression
• A Study to Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy
• An Adaptive Algorithm-Based Approach to Treatment for Adolescent Depression
• Multi-Dimensional Diagnosis,Individualized Therapy,and Management Technique for Major Depressive Disorder:Based on Clinical and Pathological Characteristics
• Melancholic Depression and Insomnia as Predictors of Response to Quetiapine in Patients With Major Depression
• Creatine for Treatment of Depression Associated With Type 2 Diabetes
• BTRX-246040 Administered Once Daily to Patients With Major Depressive Disorder
• A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)
• Cognitive Dysfunction in MDD Patients
• Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Partici
• Comparison of Anyu Peibo With Placebo in Treatment of MDD，Ⅱb
• Effects of Psilocybin in Major Depressive Disorder
• CODEPAD (Collaborative Outcomes of DEpression and Pain Associated With Delivery)
• The Omega-3 Fatty Acid Paediatric Depression Trial
• The BIO-K Study: A Single-Arm, Open-Label, Biomarker Development Clinical Trial of Ketamine for Non-Psychotic Unipolar Major Depression and Bipolar I or II Depression.
• A Study to Investigate the Safety, Tolerability and Pharmacokinetics of SUVN-911 in Healthy Subjects
• Salicylic Augmentation in Depression
• A Study of Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)
• A Diagnosis and Treatment Optimization Study of Depression Based on the Neurological Mechanism of Reward System
• A Study of Diagnosis and Treatment of Depression Based on Biological Evidence of Dopamine Reward Pathway
• Efficacy and Safety of Jiedu Tongluo Granules for Post-stroke Depression
• Effectiveness Study of Scopolamine Combined With Escitalopram in Patients With MDD
• Neural Mechanisms of Monoaminergic Engagement in Late-life Depression Treatment Response (NEMO)
• Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders
• Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks Trial
• ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)
• Continuation With Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 17 Years of Age
• Ketamine and Nitroprusside for Depression
• Cytokines, PUFA Tissue Concentrations and Treatment Selection in Antenatal MDD
• Open Trial Determining Antidepressant Effects of Omega-3 Supplementation During Pregnancy
• 54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participa
• Effectiveness of an Internet-based Intervention for the Treatment of Depression
• A Study to Evaluate the Safety and Efficacy of TS-121 as an Adjunctive Treatment for Major Depressive Disorder
• Rapid Antidepressant Effects of Leucine
• AV-101 as Adjunct Antidepressant Therapy in Patients With Major Depression
• Neurobiology of Treatment Responses in MDD
• Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
• Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in Depression
• Open Label Ketamine Treatment for Major Depressive Disorder in Veterans
• THINC-it Vortioxetine - Sensitivity to Change
• Endogenous Opioid Modulation by Ketamine
• Safety, Tolerability, PK Profile, and Symptom Response of a 7-Day Dosing With 25 mg or 50 mg Daily of REL-1017 in MDD
• Study to Treat Major Depressive Disorder With a New Medication
• 54135419SUI3001: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participa
• CSE v. Epidural for Postpartum Depression
• Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)
• Dynamics of Inflammation and Its Blockade on Motivational Circuitry in Depression
• Osteoporosis Treatment in Post-menopausal Women
• Lithium Versus Quetiapine in Treatment Resistant Depression
• Inflammation-Induced CNS Glutamate Changes in Depression
• Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder
• A Study to Evaluate SAGE-217 in Participants With Moderate to Severe Major Depressive Disorder
• NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits
• Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine
• Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy
• A Study to Evaluate SAGE-217 in Subjects With Severe Postpartum Depression
• Comparative Effectiveness Research Trial for Antidepressant Incomplete and Non-responders With TRD
• Sequential Therapy for the Treatment of Severe Bipolar Depression.
• Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive Disorder
• N-Acetyl Cysteine Supplementation in Therapy Refractory Major Depressive Disorders
• Pattern Separation, Brain Derived Neurotrophic Factors, and Mechanisms of Vortioxetine
• Optimizing Outcomes of Treatment-Resistant Depression in Older Adults
• CAMH - McMaster Collaborative Care Initiative For Mental Health Risk Factors In Dementia
• A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive Disorder
• A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-03)
• A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-02)
• Assessment of Intra-subject Variability in the Bioavailability of Chlorpromazine Hydrochloride
• A Study to Evaluate Safety and Efficacy of SAGE-547 in Participants With Moderate Postpartum Depression (547-PPD-202C)
• A Study to Evaluate Efficacy and Safety of SAGE-547 in Participants With Severe Postpartum Depression (547-PPD-202B)
• Burst Suppression Anesthesia for Treatment of Severe Depression
• Low Dose Intravenous Ketamine in Treatment Resistant Depression Patients
• Early Improvement in Individual Symptoms and Response to Antidepressants in Patients With Major Depressive Disorder
• A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)
• Hyperventilation Combined With Etomidate or Ketamine Anesthesia in ECT Treatment of Major Depression
• Placebo-controlled Trial of 5-hydroxytryptophan and Creatine for SSRI or SNRI Augmentation in Treatment Resistant Depression in Females
• A Study to Evaluate the Effects of a Single-Dose and Repeat-Administration of Intranasal Esketamine on On-Road Driving in Participants With Major Depressive Disorder
• Study of the Efficacy and Safety of Initial Administration of 17 mg Vortioxetine Intravenously With 10 mg/Day Vortioxetine Orally in Patients With Major Depressive Disorder
• A Study to Evaluate the Efficacy, Safety and Tolerability of Fixed Doses of Intranasal Esketamine in Japanese Participants With Treatment Resistant Depression
• The Therapeutic Effect of Transcranial Direct Current Stimulation on Depression in Parkinson's Disease
• Measurement-based Care for Depression in Resource-Poor Settings
• Antidepressant Effects of Ayahuasca: a Randomized Placebo Controlled Trial in Treatment Resistant Depression
• Double-Blind Trial of Ketamine Therapy Plus or Minus Naltrexone in Treatment Resistant Depression (TRD)
• A Study to Investigate the Safety, Tolerability, and Pharmacodynamics of JNJ-54175446 in Participants With Major Depressive Disorder
• Cost- Effectiveness and Quality of Life Assessment in Major Depression Disorder
• Augmentation of Treatment-Resistant Depression With An Analog of the Neuroactive Steroid Allopregnanolone
• The Use of Low Dose Prophylactic Naloxone Infusion to Prevent Respiratory Depression With Intrathecal Morphine.
• The UTHealth Ketamine Project
• 5 Alpha Reductase Inhibitors And The Risk Of Suicide And Depression
• A Study of Chinese Medicine Treating Depression
• Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Patients With Major Depressive Disorder (MDD) From 7 to 18 Years of Age
• Multimodal Imaging of ECT Effects
• Treatment Outcome in Major Depressive Disorder
• A Trial of Dextromethorphan for Treatment of Major Depressive Disorder
• Dimensional Approach to Evaluate Reward Processing in Major Depressive Disorder Pre- and Post-Desvenlafaxine Treatment
• SSRIs vs. TCAs for Depression in ALS Patients
• Vortioxetine for the Treatment of Major Depression and Co-morbidities After Traumatic Brain Injury (TBI)
• The Effect of Cortisol Administration on Neural Correlates of Emotion in Depression
• Study of Oral Ketamine Versus Placebo for Treating Depression in Patients Undergoing Treatment for Cancer
• Sudarshan Kriya Yoga and Cardiac Autonomic Control in Patients With Anxiety-Depression Disorders
• Respiratory Depression in Women With BMI≥30 Underwent Spinal Anesthesia With Intrathecal Morphine in Elective C-section
• Depressed Mood Improvement Through Nicotine Dosing (Depressed MIND Study)
• Treating Caregiver Depression to Improve Childhood Asthma: Impact and Mediators
• Efficacy and Safety of S 47445 Versus Placebo as Adjunctive Treatment in Depressed Patients Not Fully Recovered From Depressive Symptoms With a Current Antidepressant Treatment
• Vital-signs-integrated Patient-assisted Intravenous Opioid Analgesia
• Trehalose as add-on Therapy in Bipolar Depression
• Effectiveness of Ascorbic Acid and Tocopherol for Depression in Elderly.
• Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive Disease
• A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant Depression
• D-cycloserine for Relapse Prevention Following Intravenous Ketamine in Treatment-resistant Depression
• Depression, Obesity and Inflammatory Markers
• Nitrous TRD Bipolar Depression
• Ketamine Anesthesia for Improvement of Depression in ECT
• Personalized Indications for CBT and Antidepressants in Treating Depression
• The Relationship Among Changes in Brain Network Activation in Adult Outpatients With Major Depressive Disorder
• A Study of L-DOPA for Depression and Slowing in Older Adults
• A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Treatment Resistant Major Depressive Disorder
• Antagonism of Opioid-Induced Respiratory Depression by CX1739 With Preservation of Opioid Analgesia
• Imaging SV2A in Mood Disorders
• Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum Depression
• A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder
• Exploratory Trial to Assess the Functionality of an Integrated Call Center for the Digital Medicine System
• Levomilnacipran ER vs. Adjunctive Quetiapine for Adults With Inadequate Relief With SSRIs in MDD
• A Pilot Study Investigating the Efficacy of Minocycline and N-Acetyl Cysteine for Bipolar Depression
• Patient Stratification and Treatment Response Prediction in Neuropharmacotherapy Using Hybrid Positron Emmission Tomography/Magnetic Resconance Imaging (PET/MR)
• Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 12 to 17 Years With Major Depressive Disorder (MDD)
• Active Reference (Fluoxetine) Fixed-dose Study of Vortioxetine in Paediatric Patients Aged 7 to 11 Years With Major Depressive Disorder (MDD)
• Minocycline and Celecoxib as Adjunctive Treatments of Bipolar Depression
• A Study to Evaluate Pharmacokinetics, Safety and Tolerability of Extended-release Bupropion Hydrochloride Tablets in Chinese Healthy Volunteers
• Study of NSI-189 for Major Depressive Disorder
• The Effects of JNJ-39393406 on Psychometric Performance and Residual Depressive
• Allogeneic Human Mesenchymal Stem Cells (hMSCs) Infusion in Patients With Treatment Resistant Depression
• Study of Neural Responses Induced by Antidepressant Effects
• Study on the Efficacy, Safety, and Tolerability of Cariprazine Relative to Placebo in Participants With Bipolar I Depression
• Study of the Efficacy of a Fixed-dose Regimen of Cariprazine Compared to Placebo for Treatment of the Depressive Episode in Participants With Bipolar I Disorder
• The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy
• A Six Week, Randomized, Double-Blind Placebo-Controlled, Suvorexant Augmentation Study of Antidepressant Treatment of Major Depressive Disorder With Residual Insomnia
• Neurorestorative Effects of Electroconvulsive Therapy (ECT) in Patients With Severe Late Life Depression
• Open-Label Placebo for the Treatment of Depression
• Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for Depression
• Ketamine for Relapse Prevention in Recurrent Depressive Disorder
• Tocilizumab Augmentation in Treatment-Refractory Major Depressive Disorder
• Ketamine as an Alternative Treatment to ECT in Major Depressive Disorder
• Efficacy and Safety Analyses of Mirtazapine in NSCLC Patients With Depression
• Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial
• Intra-nasal vs. Intra-venous Ketamine Administration
• Can Acupuncture Treat Post-stroke Depression?
• Vortioxetine for MDD, Cognition, and Systemic Inflammatory Biomarkers
• Combined Cytidine and Creatine-containing Drug in the Treatment of the Bipolar Depression
• Efficacy of Trial-Based Cognitive Therapy and Behavioral Activation in Treatment of Depression
• SSRI Effects on Depression and Immunity in HIV/AIDS
• Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa
• A Study to Evaluate SAGE-547 in Participants With Severe Postpartum Depression
• Clinical Trial of the Use of Ketamine in Treatment Resistant Depression
• Clinical Trial Evaluating ITI-007 as an Adjunctive Therapy to Lithium or Valproate for the Treatment of Bipolar Depression
• Clinical Trial Evaluating ITI-007 (Lumateperone) as a Monotherapy for the Treatment of Bipolar Depression
• Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression.
• The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive Impairment
• MetAbolism vaRiability of VEnLafaxine
• Ketamine Infusion for Adolescent Depression and Anxiety
• Effects of Low-dose Ketamine as an Adjunct to Propofol-based Anesthesia for Electroconvulsive Therapy
• Adjunctive Treatment of Major Depression Utilizing Auricular Acupuncture
• Ketamine Infusions for PTSD and Treatment-Resistant Depression
• Efficacy of Nepeta Menthoides Extract on Anxiety of Patients With Depression: a Double-blind Randomized Controlled Clinical Trial
• Neurobiological Underpinnings of Placebo Response in Depression
• TAK-653 Escalating Single and Multiple Dose Study in Healthy Participants
• Ketamine for Treatment Resistant Late-Life Depression
• Omega-3 Fatty Acids for Major Depressive Disorder With High Inflammation: A Personalized Approach
• Predictors of Treatment Response in Late-onset Major Depressive Disorder
• Ketamine for Depression: An MRI Study
• Trial to Evaluate Efficacy of Pharmacogenetic Information Obtained With NEUROPHARMAGEN in Treatment of MDD Patients
• Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment for Treatment Resistant Depression
• Study of Ibuprofen Effects on Brain Function
• Preventing Postpartum Depression With Intranasal Oxytocin
• Effect of a Single Nights' Wake Followed by Bright Light Therapy for Severe Depression
• An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress
• A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression
• A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression
• Antidepressant Effects of the Glycine Receptor Antagonist AV-101 (4-chlorokynurenine) in Major Depressive Disorder
• The Effect of Patient and Investigator Expectation on the Efficacy of Escitalopram in the Treatment Depression
• A Safety, Efficacy and Biomarker Study of JNJ-42847922 in Participants With Major Depressive Disorder
• The Serotonin Transporter Availability for Prognosing Major Depressive Disorder (MDD) Treatment and Detecting MDD
• Predictors of Opioid-Induced Respiratory Depression (OIRD)
• An Efficacy and Safety Study of Sirukumab in Participants With Major Depressive Disorder
• Acupuncture for Ischemic Post-stroke Depression
• Noradrenergic Activity, Cognition and Major Depressive Disorder
• Effect of Lactobacillus Plantarum 299v Supplementation on Major Depression Treatment
• Trial of Levomilnacipran in Geriatric Depression
• Role of Magnesium Supplementation in the Treatment of Depression
• Acute Myocardial Necrosis and Depression: Antiplatelet Effect of Reuptake Inhibition of Serotonin
• Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder
• A Study of Intermittent Doses of CERC-301 in MDD
• eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients
• Adjunct Minocyline in Treatment-resistant Depression
• Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery Disease
• The Effect of MElatonin on Depression, Anxiety, CIrcadian and Sleep Disturbances in Patients After Acute Myocardial Syndrome
• Ketamine for Preventing Depression in Patients Undergoing Treatment for Pancreatic or Head and Neck Cancers
• Predictors of the Outcome of Late Life Depression
• A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder
• A Study of the Safety, Tolerability, and Pharmacokinetics of Multiple-Ascending Dose Basimglurant in Healthy Subjects and in Patients With Major Depressive Disorder (MDD)
• Safety and Efficacy of Levomilnacipran ER in Adolescent Participants With Major Depressive Disorder
• MRI Studies of Emotion in Depression
• Identification of Genetic Markers and Predictors of Antidepressant-induced Suicidality in Youth Depression
• Effectiveness and Safety of Electro-acupuncture for Mild-to-moderate Perimenopausal Depression
• Effects of Low Dose Ketamine Given at Induction of Anesthesia on Postoperative Mood in Patients With Depressive Symptoms
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
• miRNAs, Suicide, and Ketamine - Plasma Exosomal microRNAs as Novel Biomarkers for Suicidality and Treatment Outcome
• A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
• Ketamine for Depression Relapse Prevention Following ECT
• Clinical Registry of Patients Under Treatment With Atypical Antipsychotics
• A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise
• Therapy With an Oxytocin Adjunct for Major Depression
• Ketamine Trial for the Treatment of Depression
• Evaluation of the Safety of Adjunct Brexpiprazole in Elderly Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Treatment
• A Phase II Study of PDC-1421 Capsule to Evaluate the Safety and Efficacy in Patients With Major Depressive Disorder
• Comparison of Yuxintine With Placebo in Treatment of MDD
• A Phase 3 Study of Lu AA21004 in Patients With Major Depressive Disorder
• Late-Life Stress and Inflammation
• Comparison of Anyu Peibo With Placebo in Treatment of MDD
• Behavioral Activation and Varenicline for Smoking Cessation in Depressed Smokers
• Subanesthetic IV Bolus Ketamine in the Treatment of Acute Depression
• Improving Therapeutic Learning in Depression: Proof of Concept
• Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22)
• Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)
• Study of Safety, Tolerability and Pharmacokinetics of NRX-1074 in Normal Healthy Volunteers
• 12-Week Study Evaluating the Efficacy, Safety, and Tolerability of Adjunctive Infliximab for Bipolar I/II Depression
• Biomarkers of Neuroinflammation and Anti-Inflammatory Treatments in Major Depressive Disorder
• Efficacy of Repeated Ketamine Infusions for Treatment-resistant Depression
• A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}
• 5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females
• Neurochemical, Metabonomics and Neuroimaging Characterization of TCM Diagnostic Subtypes of Major Depression Disorder
• Effect of Nicotine on Brain Reward Pathways
• Characterization of the Prosocial and Prosexual Effects of GHB
• Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine
• Connectivity Affecting the Antidepressant REsponse Study
• Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis
• Microbiome of Depression & Treatment Response to Citalopram
• Music Therapy in Obsessive Compulsive Disorder
• Intranasal Ketamine for Late-Life Depression and Suicidal Ideation
• Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder
• A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder
• Evaluate SAGE-547 in Female Patients With Severe Postpartum Depression
• Efficacy of Vortioxetine on Cognitive Dysfunction in Working Patients With Major Depressive Disorder
• Efficacy of Vortioxetine on Cognitive Dysfunction in Patients With Partial or Full Remission of Major Depressive Disorder
• Randomized，Controlled and Open-label Study of Buspirone add-on Treatment in Patients With Major Depression Disorder
• Efficacy of Vortioxetine Versus Escitalopram on Cognitive Function in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive Disorder
• Multiple Ascending Dose Study in Healthy Subjects to Evaluate the Safety, Tolerability, and Pharmacokinetics of LY03005
• A New Treatment Approach for Major Depressive Disorder Based Upon Targeting Monoamine Oxidase A (MAO-A)
• Integral Assessment in Unipolar Depression
• Effect of the Addition of Ketamine to Sevoflurane Anesthesia in Electroconvulsive Therapy
• Efficacy of Pain Treatment on Depression in Patients With Dementia
• Minocycline as an Adjunct for the Treatment of Depressive Symptoms: Pilot Randomized Controlled Trial
• Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine
• CBT Versus Selective Serotonin Reuptake Inhibitor For Treatment Of Depression In Temporal Lobe Epilepsy Patients
• Perimenopausal Effects of Estradiol on Reward Responsiveness
• Cost-effectiveness of a Non-Pharmacological Treatment (Active Monitoring) vs. a Pharmacological Treatment for Major Depression in Primary Care.
• Biosignatures of Latuda for Bipolar Depression
• Bupropion for Depression in ESRD Patients on Hemodialysis
• Prophylactic Use of Postpartum Sertraline to Prevent Postpartum Depression
• Vortioxetine for Menopausal Depression
• Study to Evaluate the Efficacy of Duloxetine in Outpatients With Major Depressive Disorder and Pain
• Observational Study to Assess a 6-months Treatment With Gladem
• Study to Assess Clinical Response of Duloxetine in Patients Hospitalized for Severe Depression
• Pilot Study: Combining Nutritional Supplements With Standard Antidepressant to Treat Depression.
• Ketamine Infusions for Major Depression Disorder
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 Study
• Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and Irritability
• Clinical Study of Generic and Brand Bupropion in Depression
• Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer
• Desvenlafaxine in Opioid-Dependent Patients
• Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress
• Open Label Extension for GLYX13-C-202, NCT01684163
• Oxytocin and Dyadic Psychotherapy in the Treatment of Post Partum Depression
• Study to Evaluate the Efficacy, Safety and Tolerability of Bupropion Hydrochloride Extended-release Tablet, and Escitalopram Oxalate Capsule in Subjects With Major Depressive Disorder
• Comparison of Orcinoside With Placebo in Treatment of MDD
• The Measurement-based Care in Patients With Depressive Disorder: A Randomized Controlled Trial
• Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients
• Effects and Consequences for Mother and Child From Treatment for Depression
• Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD.
• Buprenorphine Used With Treatment Resistant Depression in Older Adults
• Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine
• Biomarkers of Fast Acting Therapies in Major Depression
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-3 Study
• A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - the FORWARD-4 Study
• Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
• Study to Treat Major Depressive Disorder (MDD) With a New Medication
• A Long-Term Safety Study of ALKS 5461
• Nitrous Oxide as Treatment for Major Depression - a Pilot Study
• The ISLAND Study: InSuLa Assessed Needs for Depression
• Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder
• A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for Suicide
• Serotonin Transporter Genetic Variation and Amygdala Responses to Antidepressant Medications in Major Depression
• Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder
• Ketamine Alcohol (in Treatment-Resistant Depression)
• A Randomised Trial of Sertraline, Cognitive Behaviour Therapy & Combined Therapy for Postnatal Depression
• OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females
• Effects of Bupropion in Depression
• Ketamine for Depression and Suicide Risk
• Parallel Group, Multiple Dose Pharmacokinetics Study of Five Antipsychotic Medications in Psychiatric Participants
• Trazodone Once a Day in Major Depression Disorder
• A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)
• Developing New Clinical Management Strategies
• Ketamine in Adolescents With Treatment-Resistant Depression
• Evaluation of an Integrated Microfinance and Depression Care Program for Women
• Study of Intravenous NRX-1074 in Patients With Major Depressive Disorder
• A Study to Investigate the Effect of JNJ-42847922 on Polysomnography Measures in Patients With Major Depressive Disorder With Insomnia Who Are Stably Treated With Antidepressants
• The Efficacy And Cognitive Impairment Of Modified Electroconvulsive Therapy
• Adjunctive Mixed Salts Amphetamine (MSA) for Depressed Adults With Incomplete Response to Current Antidepressant Therapy (ADT)
• Omega 3 for Treatment of Depression in Patients With Heart Failure
• Comparative Trial of Antidepressant Treatment Models in HIV Care in Uganda
• Safety, Tolerability and Pharmacokinetics Study of LY03005
• Beta-arrestins and Response to Venlafaxine in Major Depressive Disorder (MDD) (DEPARRESTCLIN)
• Does Enhanced Glutamate Transporter Function Produce Antidepressant Effects in People With Major Depression?
• An Open Prospective Trial of IV Ketamine in Suicidal Adolescents
• Assess the Efficacy and Safety of ASC-01 in Patients With Major Depressive Disorder
• Lurasidone Pediatric Bipolar Study
• Preliminary Study to Investigate the Effect of rTMS and SSRI Antidepressants on Leukocyte Expression of the C-FOS and DUSP1 Genes in Patients Treated for Depression
• PRJ2215: Assessment of Buproprion Misuse/Abuse 2004-2011
• The Effect of Ketamine on Mechanises Underlying Suicidal Ideation and Drug-resistant Major Depression
• Probiotics and the Microbiome: Clinical Intervention Trial for Anxiety and Depression
• Imaging Dopamine Release in Depression
• The Effects of Vilazodone on Glutamate in the Anterior Cingulate Cortex in Anxious Unipolar Depressives
• Objective Diagnostic Markers and Personalized Intervention in MDD Patients
• Omega-3 for Depression and Other Cardiac Risk Factors - 2
• An Adaptive Treatment Strategy for Adolescent Depression-Continuation
• Study to Evaluate Cognitive Functioning in Remitted Depression During Treatment With Fluvoxamine
• Switching From Generic Selective Serotonin Reuptake Inhibitors (SSRIs) and Selective Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) to Three Different Dose Initiation Strategies With Vilazodone
• Safety and Efficacy Study Comparing ETS6103 With Amitriptyline in the Treatment of Major Depressive Disorder (MDD)
• Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Active Adults, 18 to 35 Years Old, With Major Depressive Disorder Who Are in a School or Work Environment
• Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
• Brexpiprazole as Adjunctive Therapy With Major Depressive Disorder and an Inadequate Response to Previous Adjunctive Therapy
• Smoking Cessation for Depression and Anxiety Treatment
• A Study to Evaluate the Safety and Efficacy of Intranasal Esketamine in Treatment-resistant Depression
• Electrophysiologic Parameters and Biomarkers Predicting Treatment Response in Patients With Major Depressive Disorder
• A Phase III Study of SM-13496 in Patients With Bipolar I Depression.
• A Study of Sustained-Release Desvenlafaxine Hydrochloride for the Treatment of Major Depressive Disorder
• Efficacy and Safety Study of Desvenlafaxine in the Treatment of Vascular Depression
• Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults
• Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat
• Depression in the Elderly and Cerebral Amyloid Plaques: Characterization by [18F] AV-45 Affectives Symptoms and Amyloïd Plaques (ASAP)
• A Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depressive Disorder
• Silybin Supplementation During HCV Therapy With Pegylated Interferon-α2b Plus Ribavirin Reduces Depression and Increases Work Ability
• Action of Ketamine in Treatment-Resistant Depression
• Long-term Safety and Tolerability Study of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder
• Supplemental Transcranial Magnetic Stimulation (TMS) vs. Standard Medication Monotherapy for Treating Major Depression: An Exploratory Field Study
• Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy
• Study of Brexpiprazole as Adjunctive Treatment of Sleep Disturbances in Patients With Major Depressive Disorder
• A Comparison of Medication Augmentation and PST in the Treatment of Depression in Older Adults
• A Randomized, Double-Blind, Placebo-Controlled, Sequential Parallel Study of CERC-301 in the Adjunctive Treatment of Subjects With Severe Depression and Recent Active Suicidal Ideation Despite Antidepressant Treatment
• Comparing Ketamine and Propofol Anesthesia for Electroconvulsive Therapy
• Mechanisms of Antidepressant Non-Response in Late-Life Depression
• Lithium for Suicidal Behavior in Mood Disorders
• Oral Multiple-dose Study in Patients With Major Depressive Disorder
• Double-Blind, Placebo-Controlled Trial of Ketamine Therapy in Treatment-Resistant Depression (TRD)
• Placebo Effects in the Treatment of Depression: Cognitive and Neural Mechanisms
• Comparison of Plasma Concentration Changes Between Two Types of Tablets of FK949E Administration to Patients With Major Depressive Disorder
• Effects of Treatment on Decision-making in Major Depression
• Efficacy and Safety of Paroxetine Controlled Release for Major Depressive Disorder in Irritable Bowel Syndrome Patients
• Proof-of-Concept Trial of CERC-501 Augmentation of Antidepressant Therapy in Treatment-Resistant Depression
• Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD)
• Enhancing the Effectiveness of Electroconvulsive Therapy in Severe Depression
• Negative Valence Brain Targets and Predictors of Anxiety and Depression Treatment
• Study to Evaluate Safety and Tolerability of FK949E in Elderly Patients With Major Depressive Disorder
• Brain Aging and Treatment Response in Geriatric Depression
• Frontal Hypoperfusion Effects on Antidepressant Outcomes in Late-Life Depression
• Interpersonal Psychotherapy for Treatment Resistant Depression
• Escitalopram, Placebo and tDCS in Depression: a Non-inferiority Trial
• Vitamin D Supplementation for Bipolar Depression
• Nuedexta in Treatment-Resistant Major Depression
• Ketamine as an Augmentation Strategy for Electroconvulsive Therapy (ECT) in Depression
• PET and MRI Brain Imaging of Bipolar Disorder
• Ketamine Plus Lithium in Treatment-Resistant Depression
• Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive Disorder
• Memantine Plus Es-citalopram in Elderly Depressed Patients With Cognitive Impairment
• Low-Dose Naltrexone (LDN) for Depression Relapse and Recurrence
• Study to Evaluate Safety and Tolerability of FK949E in Patients With Major Depressive Disorder
• A Study to Evaluate the Impact of Escitalopram on Quality of Life and Social Functionality in Patients With Major Depressive Disorder With Anxiety Symptom
• Ketamine for Treatment-resistant Depression: A Multicentric Clinical Trial in Mexican Population
• Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity
• Does Vilazodone Help With Antidepressant-associated Sexual Dysfunction?
• The TRUST Study - Depression Substudy
• Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive Disorder
• Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
• Efficacy and Safety of Brexpiprazole as Adjunctive Treatment in Elderly Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment
• An Open Study of Tipepidine Hibenzate in Adolescent Patients With Depression
• Pharmacotherapy and Psychotherapy for MDD After Remission on Psychology and Neuroimaging
• Comparison of Venlafaxine and Fluoxetine in the Treatment of Postmenopausal Women With Major Depression
• An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms
• A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe Depression
• Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI
• The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subjects With Depression
• A Study of Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing
• A Study of Fluoxetine in Major Depressive Disorder (MDD) Short-Term Dosing
• Asenapine for Bipolar Depression
• Uridine Adolescent Bipolar Depression Randomized Controlled Trial
• Omega 3 FA Supplements as Augmentation in the Treatment of Depression
• An Adaptive Treatment Strategy for Adolescent Depression
• Antidepressants During Pregnancy and Lactation: Pharmacokinetics and Clinical Implications
• Effects of Cerebral Hypoperfusion and Its Reversal on Late-Life Depression
• Neurobiological Bases of Placebo Response in Major Depressive Disorder
• Study of Respiratory Depression When Using a Hydromorphone Pain Protocol
• A Multiple Ascending Oral Dose Evaluation of the Safety, Tolerability, and Pharmacokinetics of DSP-1053 and Its Metabolites in Healthy Subjects and in Subjects With Major Depressive Disorder
• A Dose Escalation Phase I Study of PDC-1421 Capsule Targeting in Depression
• Impulsivity and Thought Process Disorder in Patients With Active Suicidal Ideation and Depression
• Trial of Ketamine and Lithium Therapy in Bipolar Depression
• Algorithm Guided Treatment Strategies for Major Depressive Disorder
• Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and Parturition
• Open Trial of Duloxetine in Outpatients With Irritable Bowel Syndrome Symptoms and Co-Morbid Major Depression
• Late-life Depression and Cerebral Perfusion
• Efficacy and Safety Curcumin in Depression
• Paroxetine/Bupropion in Depression With Suicide Attempt or Thoughts: fMRI Study
• Double-Blind Treatment of Major Depressive Disorder With Vilazodone
• Efficacy and Safety Study of ABT-436 in Major Depressive Disorder
• Comparison of Behavioral Activation and Antidepressant Medication in the Treatment of Adolescents With Depression
• Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
• Emotional and Cognitive Control in Late-Onset Depression
• A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
• Study to Evaluate the Effect and Safety of Quetiapine Extended Release (XR) (FK949E) in Major Depressive Disorder
• Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With Cancer
• Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)
• Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)
• Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration
• Riluzole Augmentation Pilot in Depression (RAPID) Trial
• An Investigation of Early Life Stress and Depression
• Ketamine in the Treatment of Suicidal Depression
• Role of Inflammation Factors and Insulin Resistance in Major Depressive Disorder
• Aripiprazole (Abilify®) as an Adjunctive Treatment for Inadequate Response in Major Depressive Disorder
• VITAL-DEP: Depression Endpoint Prevention in the VITamin D and OmegA-3 TriaL
• PET Imaging of mGLuR5 With Drug Challenge
• A Study of Olanzapine and Fluoxetine for Treatment-resistant Depression
• Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants
• Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer
• Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
• Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression
• Ketamine Versus Placebo for Treatment Resistant Major Depressive Disorder
• Open Treatment of Minocycline in Geriatric Depression
• Combination Treatment Study for Memory Impairment and Depression
• Canadian Biomarker Integration Network for Depression Study
• Study of Placebo Without Deception Versus Standard Antidepressant for Major Depressive Disorder
• A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant Depression
• Homeopathic Treatment for Depression in Peri- and Postmenopausal Women
• Oral Tyramine Pressor Response Study of CX157 Tablets in Healthy Male Volunteers
• Sequence Towards Remission in Depression
• A Study of Ketamine in Patients With Treatment-resistant Depression
• Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED)
• Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder
• Venlafaxine for Depression in Alzheimer's Disease (DIADs-3)
• Vilazodone for Treatment of Geriatric Depression
• Exploratory Study of the Effects of Vortioxetine (Lu AA21004) on Cognition and Blood Oxygen Level Dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Signals in Subjects Remitted From Depression and in Controls
• Evaluation of the Potential Effects of SSR149415 on the Hypothalamic-pituitary-adrenal Axis in Outpatients With Major Depressive Disorder
• Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder
• LEPR Polymorphism Weight Gain by Mirtazapine in Late Life Depression
• Bupropion & Cardio Birth Defect (Slone)
• Lexapro®'s Efficacy After Dose Escalation in Remission Study
• Efficacy of Quetiapine XR Versus Divalproex on Clinical Outcome Quality of Sleep and Quality of Life in Bipolar Depression
• Ketamine Infusion for Treatment-resistant Major Depressive Disorder
• A Study of JNJ-40411813 as Supplementary Treatment to an Antidepressant in Adults With Depression and Anxiety Symptoms
• Citalopram vs Clomipramine vs Placebo in Recurrent Depression
• Open Study Assessing the Feasibility of Minocycline in Patients With Unipolar Depression
• Study of Ketamine as an Antidepressant in Major Depressive Disorder
• Safety and Efficacy of Vilazodone in Major Depressive Disorder
• Study of Vortioxetine (Lu AA21004) in Major Depressive Disorder in Asian Countries
• Major Depressive Disorder - Understanding The Link Between The Brain And The Heart
• Efficacy of Lu AA21004 on Cognitive Dysfunction in Major Depressive Disorder
• Pioglitazone in Patients With Mood Disorders
• Comparison of Treatment Effect of Chinese Medicine and Western Medicine on Depression in China and America
• Ketamine in the Treatment of Depression
• Glutamatergic and GABAergic Mediators of Antidepressant Response in Major Depression
• Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks
• Vascular Augmentation of Late-life Unremitted Depression (VALUeD)
• Efficacy Study of Botox for Depression
• Safety and Efficacy of MK-6096 as Adjunctive Therapy in Participants With Major Depressive Disorder And Partial Response to Antidepressant Monotherapy (MK-6096-022)
• Ketamine for Depression and Alcohol Dependence
• Serotonin Transporter Density in Late-life Depression With and Without Dementia
• Repeated Partial Sleep Deprivation to Augment SSRI Response in Depression
• Cytidine- and Creatine-Containing Drug in Treating Bipolar Depression
• Neuroimaging Study of Bupropion Treatment in Patients With Major Depressive Disorder
• Desvenlafaxine vs. Placebo Treatment of Chronic Depression
• Functional Outcome in Postpartum Depression in Women Treated With Desvenlafaxine
• Escitalopram in the Treatment of Postpartum Depression
• Quetiapine in the Treatment of Postpartum Depression (PPD) in Bipolar Disorder (BD), Type II
• Decreasing the Use of Unmodified Electroconvulsive Therapy (ECT) in an Indian Hospital
• A Clinical Study of Trazodone Hydrochloride Prolonged-Release Tablets for Treatment of Depression
• Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects
• Creatine as a Treatment Option for Depression in Methamphetamine Using Females
• Minocycline for Bipolar Depression
• A Study to Evaluate ALKS 5461 in Subjects With Major Depressive Disorder (MDD)
• Effect of Antidepressants on White Matter Structure
• Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder
• Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder
• A Study of Vortioxetine (Lu AA21004) in Comparison to Agomelatine in Adults Suffering From Major Depression With Inadequate Response to Previous Medication
• Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD)
• Cardiovascular Effects of Agomelatine and Escitalopram in Patients With Major Depressive Disorder (MDD)
• A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder
• A Positron Emission Topographic (PET) Study on Depression Patient With Electroacupuncture
• Bipolar Depression and Inflammation
• Stimulant Enhancement of Well-Being Therapy for Depression
• Interventional Study of Wellbutrin XL in Major Depressive Disorder With Atypical Features
• Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders
• Safety, Efficacy, and Tolerability of Vilazodone in Major Depressive Disorder
• Safety and Efficacy of Vilazodone in Major Depressive Disorder
• Tibolone and Placebo in Adjunct to Antidepressant Medication for Women With Menopausal Depression
• Safety and Efficacy of Cariprazine as an Adjunctive to Antidepressant Therapy in Major Depressive Disorder
• Neurocognition and Work Productivity in Major Depressive Disorder (MDD)
• Randomized Double Blinding Controlled Study on" Jia Wei Xiao Yao Jiaonang" Treating Mild to Moderate Major Depressive Disorder
• Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
• Efficacy Study of Mirtazapine to Treat Interferon-related Depression During Antiviral Therapy for Hepatitis C
• Iloperidone Augmentation of SSRIs for Patients With Major Depressive Disorder With Residual Anger and Irritability
• Timing of Postpartum Depot Medroxyprogesterone Acetate Administration on Breastfeeding, Contraceptive Continuation, and Depression
• A Study to Evaluate the Effect of Clarithromycin on LY2216684
• A Study to Evaluate the Effect of Genotype on LY2216684
• Magnetic Resonance Imaging Study of Cognitive-Behavior Therapy for Major Depressive Disorder
• ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment
• Analisis of Facors Involved in Antidepressant Treatment Response of Major Depressive Disorder
• Study of Safety & Tolerability of OPC-34712 as Adjunctive Therapy in Treatment of Adult Patients With Major Depressive Disorder
• Pharmacokinetics and Safety of Desvenlafaxine in Korean Healthy Subjects Following Single and Multiple Oral Doses of Desvenlafaxine Succinate Sustained Release Tablet
• Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD)
• MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
• The Effects of Sertraline on Depression in Parkinson's Disease
• Combination of Antidepressants and Fingolimod Relapsing-remitting Multiple Sclerosis (RRMS) Patients With Depression
• SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study
• Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
• Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
• SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)
• Wake Therapy in the Treatment of Depression
• Tranylcypromine Treatment of Bipolar Depression
• Aripiprazole for the Augmentation of Antidepressant Therapy
• Minocycline and Aspirin in the Treatment of Bipolar Depression
• Melatonin Agonist Effects of Tasimelteon Versus Placebo in Patients With Major Depressive Disorder
• Sustaining Remission of Psychotic Depression
• A PET Study in Healthy Volunteers
• Emotional Processing in Healthy Volunteers in the Presence of an Investigational Anxiolytic
• Exploring Biomarkers for Depression
• Major Depressive Disorder With Mixed Features - Extension
• Major Depressive Disorder With Mixed Features
• Efficacy Study of Vortioxetine on Cognitive Dysfunction in Adult Patients With Major Depressive Disorder
• VA Augmentation and Switching Treatments for Improving Depression Outcomes
• Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
• Treatment of Depression in Parkinson's Disease
• Lithium Versus Paroxetine in Major Depression
• Pharmacokinetics - Pharmacodynamic Study of HT-2157 in Healthy Subjects and in Patients With Major Depressive Disorder
• Study Using Pregnenolone to Treat Bipolar Depression
• Buprenorphine for Treatment Resistant Depression
• Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care for Depression
• Evaluating the Efficacy of Adjunctive Minocycline for the Treatment of Bipolar Depression
• Safety, Tolerability, and Efficacy of Cariprazine in Participants With Bipolar Depression
• Japanese Phase 1 Multiple Ascending Dose (MAD) Study
• Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive Disorder
• The Treatment of Depression With Botulinum Type A Toxin
• Treatment Resistant Geriatric Depression in Primary Care
• Inflammatory Markers and Cognitive Function in Major Depression
• Exploring the Effects of Coenzyme Q10 on Bioenergetics Metabolism in Geriatric Bipolar Depression
• A Study to Evaluate the Effect of Food on LY2216684
• A Study to Evaluate the Effect of Activated Charcoal on the Absorption of LY2216684 in Healthy Subjects
• Aripiprazole and Resistant Postpartum Depression
• ALK33BUP-201: Safety and Tolerability Study of ALKS 33-BUP (ALKS 5461) Administration in Subjects With MDD
• Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder
• A Study of LY2216684 in Healthy Participants
• Safety and Efficacy of Levomilnacipran ER (Levomilnacipran SR) in Major Depressive Disorder
• Antiglucocorticoid Augmentation of antiDepressants in Depression
• A Study of LY2216684 in Healthy Females
• A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
• A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD
• A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
• A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD
• A Study of LY2216684 in Participants With Major Depression Disorder
• Electroencephalography (EEG) Signal Processing
• Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression
• Lexapro for the Treatment of Traumatic Brain Injury (TBI) Depression & Other Psychiatric Conditions
• Investigation of Tibolone and Escitalopram in Perimenopausal Depression
• Ketamine Anesthesia in Electroconvulsive Therapy
• Vortioxetine (Lu AA21004) 10 and 20 mg for Treatment of Major Depressive Disorder With Sexual Dysfunction
• The Quietude Study: Quetiapine Use for Agitated Depression
• Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
• Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)
• Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
• Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
• Neurophysiologic Monitoring of Antidepressant Treatment
• The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope
• The Effect of Melatonin on Depression, Anxiety, Cognitive Function and Sleep Disturbances in Breast Cancer Patients
• Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder
• Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients
• Omega-3 and Therapy Study for Depression
• Paxil CR Bioequivalence Study Brazil - Fed Administration
• Study of Probiotic GanedenBC30 for Irritable Bowel Syndrome and Major Depressive Disorder
• Open-label Safety Extension Study of 15 and 20 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults
• A Paroxetine- and Placebo-Controlled Study of 50 mg/Day and 100 mg/Day of EB-1010 Among Outpatients With Major Depressive Disorder Who Have Responded Inadequately to Prior Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine
• Paxil CR Bioequivalence Study Brazil
• Pipamperone/Citalopram (PNB01) Versus Citalopram (CIT) and Versus Pipamperone (PIP) in Major Depressive Disorder (MDD)
• Study Assessing the Safety and Therapeutic Effect of Buprenorphine in MDD Patients
• Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major Depression
• Comparison of Tianeptine Versus Escitalopram Patients Major Depressive Disorder
• Use of Ketamine to Enhance Electroconvulsive Therapy (ECT) in Depression
• Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder
• Perimenopausal Estrogen Replacement Therapy Study
• The Use of Ketamine as an Anaesthetic During Electroconvulsive Therapy
• The Effect of Problem Solving Therapy and Antidepressant Therapy on Cerebral Perfusion and Brain Derived Neurotropic Factor (BDNF) in Depressed Elders
• Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression
• Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
• Intranasal Ketamine in Treatment-Resistant Depression
• Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ Depression
• A Study in Prevention of Re-emergence of Depression Symptoms
• A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder.
• Depression Care Management for Depressed Elders in China Primary Care
• Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression
• Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant Depression
• The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
• A Study of the Effect of LY2216684 on Lorazepam
• Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
• A Study of LY2216684 and Digoxin in Healthy Subjects
• A Study of LY2940094 in Major Depressive Disorder
• A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors
• A Study of LY2216684 in Healthy Participants Receiving Albuterol or Propanolol
• A Study of LY2216684 and Warfarin in Healthy Subjects
• A Study of LY2216684 and Theophylline in Healthy Subjects
• A Pharmacokinetic Study on the Effect of LY2216684 on the Active Metabolite of Clopidogrel
• N-methyl-D-aspartate Antagonist (Ketamine) Augmentation of Electroconvulsive Treatment for Severe Major Depression
• Evaluate the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Extended Release as Monotherapy in the Treatment of Patients With Bipolar Depression
• Efficacy and Safety Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder
• Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Adults With Fatigue Associated With Major Depressive Disorder
• The Effects of Dopamine on Reward Processing
• A Pharmacokinetic Study of the Coadministration of LY2216684 With Sertraline
• Efficacy, Safety and Tolerability of CX157 in Treatment Resistant Depression
• Lexapro for Major Depression in Patients With Epilepsy
• Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines
• A Study to Measure if There is Any Difference in How the Body Breaks Down or Inactivates Either Fluoxetine or LY2216684 When Both of These Medicines Are Given Together.
• A Study of LY2216684 in Participants With Impaired Hepatic Function
• Oxytocin and Tibolone Adjuncts in Treatment Resistant Depression - A Pilot Study
• Single IV Dose of GLYX-13 in Patients With Treatment-Resistant Depression
• Feasibility Study of Duloxetine in the Treatment of Depression in Patients With Traumatic Brain Injury
• EScitalopram PIndolol ONset of Action
• Neurophysiologic Changes in Patients With Bipolar Depression
• Oxytocin Add-on for Stable Depressed Patients
• Efficacy and Tolerability of Riluzole in Treatment Resistant Depression
• Pharmacogenomics Studies of Antidepressants
• Quetiapine in Melancholic Depression
• Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder
• A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.
• Phase 1 Study To Test the Bioequivalence Between Two 25 mg Tablets vs. One 50 mg Tablet Under Fast/Fed Condition and Evaluate Food Effect of Desvenlafaxine Succinate Sustained Release (DVS SR)
• Safety and Efficacy Study of Citalopram and Lithium for the Treatment of Depressive Mood Disorder Symptoms
• Effects of Seroquel XR on Sleep Architecture in Patients With Major Depressive Disorder
• A Study of Flexible or Fixed Dose LY2216684 as Adjunctive Treatment for Participants With Major Depressive Disorder Who Have Had a Partial Response to Selective Serotonin Reuptake Inhibitor (SSRI) Treatment
• Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study)
• A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor
• A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
• Safety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
• Treatment Resistant Depression (Pilot)
• Efficacy and Safety of Homeopathy for Moderate Depression (Acute Phase)
• Creatine Augmentation in Veterans With SSRI-Resistant Major Depression
• Electroacupuncture Combined With Antidepressants for Post-stroke Depression
• A Fixed Dose Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
• Predictors of Response to Augmentation With Ziprasidone (Geodon®) in Major Depressive Disorder
• Bupropion and Specific Cardiovascular Malformations
• Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
• A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder (MDD)
• Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)
• A Safety Study in Participants With Major Depressive Disorder
• An Open Label Positron Emission Tomography Study in Healthy Male Subjects to Investigate Brain DAT and SERT Occupancy,Pharmacokinetics and Safety of Single Oral Doses of GSK1360707, Using 11C- PE2I and 11C-DASB as PET Ligands
• A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
• Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
• Safety and Tolerability of Vortioxetine (LuAA21004) - Open Label Extension Study
• A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder
• Lisdexamfetamine Dimesylate in Residual Symptoms and Cognitive Impairment in Major Depressive Disorder.
• Efficacy and Tolerability of Escitalopram and Duloxetine in Outpatients With Major Depressive Disorder
• 6-week Study Treatment to Evaluate the Safety and Effectiveness of AZD2066 in Patients With Major Depressive Disorder
• Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 15 and 20 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Adults
• A Fixed Dose Study of 323U66 SR in the Treatment of Major Depressive Disorder (MDD)
• Study of Depression-Ketamine-Brain Function
• Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation
• Acute Psychotherapy for Bipolar II Depression
• Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression
• Safety and Efficacy of EVT 101 in Treatment-Resistant Depression
• A Study to Evaluate the Efficacy and Safety of Add-on Therapy of Wuling Capsule in Epilepsy Patients With Depression
• ADAPT: Addressing Depression and Pain Together
• To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Patients With Major Depressive Disorder (MDD)
• Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder (DVS 3364)
• A Clinical Study for Assessment of the Efficacy and Safety of Mirtazapine (Smilon) in Depression Patients With Pain
• Fluoxetine Versus Fluoxetine Plus DU125530 in Major Depressive Disorder
• Duloxetine for Menopausal Depression
• A Safety and Efficacy Study of JNJ26489112 in Patients With Treatment-Resistant Major Depressive Disorder
• The Effects of Treatment With Sertraline for Noncardiac Chest Pain
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Patients With Major Depressive Disorder (MDD)
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
• Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
• Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)
• Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder
• Pioglitazone as an Adjunct for Moderate to Severe Depressive Disorder
• Rhodiola Rosea Therapy of Major Depressive Disorder
• A Study Of The Efficacy And Safety Of CP-601,927 Augmentation Of Antidepressant Therapy In Major Depression
• Efficacy Study of Lisdexamfetamine to Treat Bipolar Depression
• Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder
• Biomarkers for Outcomes In Late-life Depression (BOLD)
• Safety And Efficacy Of 12 Weeks Of Varenicline For Smoking Cessation In Smokers With Depression
• Carcinogenicity Study of Bupropion
• Early Prediction of Fluoxetine Response
• A Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
• Study to Evaluate the Efficacy and Safety of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
• Buprenorphine for Late-Life Treatment Resistant Depression
• A Study in Depression and Associated Painful Physical Symptoms
• First Study in Humans With GSK424887
• First Study in Humans With GSK206136
• Study Comparing Discontinuation Symptoms Of DVS SR In Subjects With Major Depressive Disorder (MDD)
• Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder
• A Study of the Neurobiology of Depression
• Magnetic Resonance Imaging Study of Lisdexamfetamine for Bipolar Depression
• Amitriptyline and Paroxetine Treatment of Major Depression
• Bupropion Hydrochloride 300 mg Extended Release Tablets Under Fasting Conditions
• Bipolar Depression Before and After Lamotrigine Treatment
• Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depression & Soft Tissue Discomfort Syndrome
• A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder
• Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
• Safety Study of F2695 SR in Major Depressive Disorder
• Efficacy Study of Transcranial Direct Current Stimulation to Treat Major Depressive Disorder
• Comparison of Depression Interventions After Acute Coronary Syndrome
• PET Biomarkers in Treatment Resistant Depression
• First Time in Human Study
• Treatment of Postpartum Depression With Psychotherapy and Add-on Sertraline
• fMRI Study of Treatment Changes in Major Depression
• Effect of Curcumin as Nutraceutical in Patients of Depression
• AZD7268 Safety and Tolerability Study
• Combination Deplin® and Antidepressant Therapy for a Major Depressive Episode (MDE)- a Retrospective Analysis
• Repeat Dose Study of Controlled-Release Paroxetine Tablets and Immediate-Release Paroxetine Tablets in Healthy Japanese Male Subjects
• A Study of Duloxetine in Major Depressive Disorder (MDD) and Associated Painful Symptoms
• Study of the Antidepressant Efficacy of a Combination Herbal Drug Preparation (NEURAPAS Balance)
• Cognitive Flexibility in Major Depression in the Course of Pharmacological and Psychotherapeutic Treatment
• Adjunctive Pregnenolone in Post-Traumatic Stress Disorder (PTSD) and Depression in Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) Veterans
• The Impact of Memantine on Electroconvulsive Therapy (ECT): Will it Improve Response and Protect Against Cognitive Problems?
• This is a Study to Determine the Antidepressant Effects of AZD6765
• SPD489 in Adults With Persistent Executive Function Impairments (EFI) and Partial or Full Remission of Recurrent Major Depressive Disorder
• A Study of Patients With Major Depressive Disorder and Residual Apathy
• Brain Imaging of Quetiapine Response in Anxious Depression
• N-methylglycine (Sarcosine) Treatment for Depression
• Clinical Study to Test a New Drug to Treat Major Depression
• The Effect on Depressive Symptoms in ECF Residents With COPD
• Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
• Safety and Efficacy of Levomilnacipran ER (F2695 SR) in Major Depressive Disorder
• Escitalopram (Lexapro) for Depression MS or ALS
• Study of Supplementation of Antidepressants With Fish Oil to Improve Time to Clinical Response
• The Role Of Omega-3 Fatty Acids In Adolescent Depression
• A Duloxetine Dosing Strategy Study in Korean Patients With Major Depressive Disorder
• Mirtazapine Reduces ICD Shocks in ICD Patients With Depression and Anxiety
• A Study in Relapse Prevention of Treatment-Resistant Depression
• Light, Ion, and Fluoxetine Efficacy (LIFE) in Depression
• Seroquel Alone Versus Seroquel With an SSRI for Depression With Psychotic Symptoms
• Dopaminergic Effects of Adjunctive Aripiprazole on the Brain in Treatment-Resistant Depression
• Study Evaluating the Effect of Desvenlafaxine on the Pharmacokinetics of Midazolam
• Cardiovascular Biomarkers and Quetiapine in Depression and Anxiety Patients
• Depression and Cardiovascular Risk Markers: Effects of Rosuvastatin Therapy
• Cytokine-Associated Depression and Social Pain
• Chronic Kidney Disease Antidepressant Sertraline Trial
• Assessment of Pituitary Adenylate Cyclase Activating Polypeptide-Brain Derived Neurotrophic Factor (PACAP-BDNF) Signaling System Involvement in Etiology and Treatment of Major Depression
• Single Dose Study of Controlled-Release Paroxetine Tablets in Healthy Japanese Male Subjects
• Botulinum Toxin for the Treatment of Depression
• Assessment of Cognitive Functioning Before and After Treatment With Duloxetine
• Citalopram Versus Citalopram Plus Pindolol in Major Depressive Disorder
• Efficacy and Feasibility of a Personalized Treatment for Depression With Co-Occurring Anxiety
• Mindfulness Based Cognitive Therapy and Antidepressant Medication in Recurrent Depression
• Lithium and Standard Therapy in Resistant Depression
• Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder Patients
• Assessing Anterior Cingulate Brain Activity in People With Late-Life Depression
• Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression
• Aging Brain Changes, Executive Dysfunction and Depression
• Personalized Indicators for Predicting Response to SSRI Treatment in Major Depression (The PRISE-MD Study)
• Brain Imaging Techniques That Predict Antidepressant Responsiveness
• Exploratory Study of SPD489 in Adults With Major Depressive Disorder (MDD) as Augmentation Therapy to an Antidepressant
• Lamotrigine Augmentation in Resistant Depression
• Functional MRI Before and After Treatment for Depression
• Safety and Efficacy Study in Patients With Major Depressive Disorder
• Bipolar Study of Seroquel XR With Pramipexole Dihydrochloride
• Identifying Very Early Response to Seroquel Extended Release (XR) Augmentation for Major Depressive Disorder
• Incomplete Response in Late Life Depression: Getting to Remission (IRL GREY)
• Duloxetine for Major Depression in Peri-/Postmenopausal Women
• Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and Women
• Relapse Prevention Study Of Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder
• Efficacy and Safety of Quetiapine Versus Quetiapine Plus Lithium in Bipolar Depression
• Long-Term Administration Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder
• A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed Dose Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
• A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder
• Study Evaluating Effexor XR in Chinese Subjects With Major Depressive Disorder
• Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder
• Compare the Efficacy and Tolerability of the Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitors (SSRIs) Used in Major Depression
• Preventing Depression in People Receiving Mechanical Ventilation in an Intensive Care Unit
• Transcranial Direct Current Stimulation (tDCS) Augmentation by D-Cycloserine as a Treatment for Depression
• Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression
• Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy)
• Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Add-on)
• Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder
• Treatment of Psychotic Major Depression With Mifepristone
• A Clinical Trial to Evaluate the Efficacy and Safety of Generic Escitalopram in Depression
• Controlled-release Paroxetine in Major Depressive Disorder (Double-blind, Placebo-controlled Study)
• Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder
• St. John's Wort Extract LI 160 for the Treatment of Atypical Depression
• Quetiapine XR Versus Sertraline in Acute Bipolar Depression as add-on Therapy
• Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder
• Safety and Efficacy of Cariprazine As Adjunctive Therapy In Major Depressive Disorder
• Safety and Efficacy of RGH-188 (Cariprazine) in Bipolar Depression
• Creatine Treatment for Female Adolescents With Depression Who Are Non-Responders to Fluoxetine or Escitalopram
• A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
• A Study in the Treatment of Children and Adolescents With Major Depressive Disorder
• Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842)
• A Study for Assessing Treatment of Patients Ages 10-17 With Bipolar Depression
• Duloxetine in Patients With Diabetic in Peripheral Neuropathic Pain With or Without Co-morbid Major Depressive Disorder
• Food and Relative Bioavailability Study
• A Study of Adjunctive Treatment to Antidepressant Therapy for Adults With Major Depressive Disorder
• Randomised Placebo-controlled Venlafaxine-referenced Study of Efficacy and Safety of 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Adults
• Efficacy Study of RX-10100 to Treat Major Depressive Disorder (MDD)
• Cognitive Behavioural Analysis System of Psychotherapy (CBASp) Versus Escitalopram in Chronic Depression
• An Investigation of Sleep Architecture in Ziprasidone-Treated Bipolar Depression
• Adding an Insulin-Sensitizing Medication to Depression Treatment for People Who Are Depressed and Overweight
• Escitalopram (Lexapro) for the Treatment of Postpartum Depression
• Study Evaluating Long-Term Safety of Desvenlafaxine Succinate Sustained Release With Japanese Adult Subjects in Major Depressive Disorder (MDD)
• The Effects of Eszopiclone and Lexapro on Prefrontal Glutamate and GABA in Depression With Anxiety and Insomnia
• Omega-3 for Peri- and Postmenopausal Depression
• Efficacy and Safety of SR58611 Compared to Placebo and Paroxetine
• Efficacy and Safety of One Single Dose of SR58611 Compared to Placebo and Paroxetine
• Study Evaluating Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder
• Quantitative Electroencephalogram (QEEG) Predictors of Response to Psychotherapy Versus Antidepressant Treatment in Depression
• An Eight-week Study of SSR411298 as Treatment for Major Depressive Disorder in Elderly Patients
• Eszopiclone Co-Administered With Escitalopram for Insomnia in Elderly Adults With Major Depressive Disorder
• Neurotrophic Factors and Depression
• Paxil Japanese Post Marketing Paediatric Study in Depression (Double-blind, Placebo Controlled Study)
• A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression
• Pediatric Bipolar Depression
• Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 5 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Elderly Patients
• Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder
• A Study of RO4917523 in Patients With Treatment Resistant Depression
• Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder
• Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) in the Treatment of Major Depressive Disorder
• Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
• A Study in Adult Patients With Major Depressive Disorder
• Liothyronine (T3) for Bipolar Depression
• Comparing Quetiapine XR Monotherapy and Augmentation With Lithium Augmentation in TRD Patients
• Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)
• Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar Depression
• Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDD
• AZD6765 Severe Major Depressive Disorder (MDD) IV
• Effectiveness of Nimodipine Plus Antidepressant Medication in Treating Vascular Depression
• A Randomized, Double-blind, Two-arm Study Comparing the Efficacy and Safety of Trazodone Contramid® OAD and Placebo in the Treatment of Unipolar Major Depressive Disorder.
• Nexalin Therapy for the Treatment of Depressive Symptoms
• Optimization of IV Ketamine for Treatment Resistant Depression
• TRIAD - Treatment of Insomnia and Depression
• Efficacy and Safety of Lu AA34893 in Patients With Major Depressive Disorder
• A Trial of SAMe for Treatment-Resistant Bipolar Depression
• Open-label Safety Extension Study of 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults
• Study of Antidepressant Efficacy of a Selective, High Affinity Enkephalinergic Agonist in Anxious Major Depressive Disorder (AMDD)
• Electroencephalography (EEG) Biomarkers of Response in Depression
• Treatment Response of Geriatric Depression
• Sinusitis and Facial Pain Disorders Anti-Depression Trial
• Quetiapine in the Treatment of Psychotic Depression - a Pilot Study
• PAXIL CR Bioequivalence Study
• fMRI Studies of Emotional Brain Circuitry in People With Major Depression
• Stress Generation and Recurrent Depression: The Role of Differential Treatment Response
• Patient Dimensions as Predictors of Varied Treatment Responses and Outcomes in Patients With Major Depression
• Postpartum Depression: Transdermal Estradiol Versus Sertraline
• Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics
• A Study of CX157 (TriRima) for the Treatment of Depression
• Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
• A Study of the Effects of a New Antidepressant Treatment (GSK561679) in Females With Major Depressive Disorder
• Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder
• Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD)
• GSK372475 PK Study in Healthy Volunteers
• Treatment of Schizoaffective Disorder Using Mifepristone
• Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression
• Lamotrigine Therapy in Geriatric Bipolar Depression
• CoQ10 in Geriatric Bipolar Depression
• The Use of a Mitochondrial Enhancement Treatment in Bipolar Disorder
• Cysteamine Therapy for Major Depressive Disorder
• Fluoxetine vs. Brief Psychotherapy for Major Depression
• Does Fish Oil Prevent Depression in Pregnancy and Postpartum?
• Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder
• Efficacy and Safety Study of a Combination Product [Drug:BCI-024 (Buspirone) and Drug:BCI-049 (Melatonin)] to Treat Major Depressive Disorder (MDD)
• A Neuroimaging and Epigenetic Investigation of Antidepressants in Depression
• A First Time in Human Study of GSK586529 in Healthy Volunteers
• Switching to Duloxetine in Patients With Depression
• Duloxetine Treatment of Major Depression and Chronic Low Back Pain For Older Adults
• Open-label Safety Extension Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults
• International Study to Predict Optimised Treatment - in Depression
• TC-5214 as add-on the Treatment of Major Depressive Disorder
• Quetiapine in Co-Morbid Depressive and Anxiety Disorders
• A Double-Blind, Placebo-Controlled Study of Aripiprazole Adjunctive to Antidepressant Therapy
• Randomized, Double-Blind, Placebo Controlled Study of Vilazodone's Efficacy, Safety, and Biomarkers of Response in Major Depressive Disorder (MDD)
• Quetiapine in Postpartum Depression
• Effects of Testosterone in Women With Depression
• A Study of Quetiapine Fumarate Sustained Release in Major Depression With Comorbid Fibromyalgia Syndrome
• Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive Disorder
• Pipamperone/Citalopram (PipCit)Versus Citalopram in the Treatment of Major Depressive Disorder(MDD)
• Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive Disorder
• Pioglitazone for the Treatment of Major Depressive Disorder Comorbid With Metabolic Syndrome
• Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive Disorder
• Escitalopram in Adult Patients With Major Depressive Disorder
• A Study Comparing Duloxetine to Other Antidepressants in the Treatment of Severe Depression
• Depression Related Improvement With Vardenafil for Erectile Response
• Efficacy and Safety of DOV 21,947 in the Treatment of Major Depressive Disorder
• Cymbalta for Depression as a Complication of Bereavement
• A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder
• Effects of Antidepressant Therapy on Brain Dopamine Transporter Activity in People With Major Depression
• Efficacy and Safety of Antidepressant Augmentation With Lamotrigine
• Efficacy Study of Escitalopram for Depression in Patients With Diabetes
• Ketamine Frequency Treatment for Major Depressive Disorder
• A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression
• A One Year Open Label Study Assessing the Safety and Tolerability of Vilazodone in Patients With Major Depressive Disorder (MDD)
• Combination Lexapro and Massage for Treatment of Depression in Older Adults
• Time to Remission of Depressive Symptoms With Combined SSRI and Ramelteon
• Effects of Cognitive Behavioral Therapy on Brain Serotonin Activity in People With Depression
• Quetiapine Extended Release Depression Symptoms
• A Study of Mifepristone vs. Placebo in the Treatment of Patients With Major Depression With Psychotic Features
• A Comparison of Sertraline-reboxetine Combination Therapy Versus Sertraline or Reboxetine Monotherapy in the Treatment of Major Depression.
• Randomised Placebo-controlled Duloxetine-referenced Efficacy and Safety Study of 2.5, 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder
• Ziprasidone Augmentation of SSRIs for Patients With Major Depressive Disorder (MDD) That do Not Sufficiently Respond to Treatment With SSRIs
• The Oral Contraceptive Pill for Premenstrual Worsening of Depression
• An Eight-week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder
• Brain Mechanisms and Targeting Insomnia in Major Depression
• Randomised Controlled Trial of Electroconvulsive Therapy (ECT) in Relapse Prevention of Depression
• Brain Imaging Study in Menopausal Women With and Without Major Depressive Disorder
• A Study of Naltrexone SR/ Bupropion SR in Overweight or Obese Subjects With Major Depression
• Treatment of Diabetes and Depression in Hispanics and African Americans and Its Effect on A1c and Quality of Life.
• Efficacy and Safety of Lu AA34893 in Patients With Bipolar Depression
• Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder
• Lamotrigine for Symptoms of Geriatric Bipolar Depression
• Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety
• Behavioral Insomnia Therapy For Those With Insomnia and Depression
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder
• Duloxetine for the Treatment of Postpartum Depression
• Does Sleep Quality Change After Switch From Wellbutrin SR to Wellbutrin XL in Patients With Major Depressive Disorder?
• Effect of Quetiapine on Sleep Architecture in Bipolar Depression and Major Depressive Disorder
• Treatment of Mood and Marriage Study (TOMMS)
• Trial to Determine the Maximum Tolerated Dose (MTD) Based on Safety and Tolerability, of Org 26576 in Participants With Major Depressive Disorder (174001/P05704/MK-8777-001)
• Escitalopram (Lexapro®) In Patients With Major Depression With Atypical Features
• Aripiprazole Augmentation of SSRI Therapy in Treatment Refractory Depression
• Study of Duloxetine vs Placebo in Treatment of Binge Eating Disorder With Depression
• Antidepressant Therapy in Treating Bipolar Type II Major Depression
• Effectiveness of Sertraline Alone and Interpersonal Psychotherapy Alone in Treating Women With Postpartum Depression
• Effectiveness of Methylphenidate in Improving Cognition and Function in Older Adults With Depression
• Dose-finding Study With Lu AA24530 in Major Depressive Disorder
• Getting Biased Treatment Study: How Psychotherapy and Antidepressants Change Brain Activity in Chronic Depression
• Efficacy of Vortioxetine (Lu AA21004) in the Prevention of Relapse of Major Depressive Episodes
• Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy
• Flexible Dose Titration Add-on Study to Treat Major Depressive Disorder
• Project to Improve Symptoms and Mood in People With Spinal Cord Injury
• Combining Medications to Enhance Depression Outcomes
• Pilot Study of Betahistine Dihydrochloride in the Treatment of Major Depression With Atypical Features
• A Safety, Efficacy and Tolerability Study of SEP-225289
• The Role of Dopamine Metabolism in the Antidepressant Effects of Sleep Deprivation and Sertraline in Depressed Patients
• Sequential Use of Fluoxetine for Smokers With Elevated Depressive Symptoms
• Open Label Trial of Fluoxetine for the Treatment of Depression in Patients With End Stage Renal Disease
• Effect of Intranasal Insulin on Depressive Symptoms in Major Depressive Disorder
• A Study of GW856553X For the Treatment of Depression
• Optimal Duration of Olanzapine Add-on Therapy in Major Depression
• The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive Functioning
• A Safety and Effectiveness Study of JNJ-18038683 in Patients With Moderate to Severe Depression
• Levetiracetam in the Management of Bipolar Depression
• Ceftriaxone in the Management of Bipolar Depression
• Effects of Adding Motivational Interviewing to Antidepressant Treatment for Hispanic Adults With Depression
• Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence
• Treatment for Bipolar Depression: Acute & Prophylactic Efficacy With Citalopram
• Biochemical Brain Changes Correlated With The Antidepressant Effect Of Thyroid Hormones
• Multi-Country Observational Study to Collect the Frequency of Sexual Dysfunction With Antidepressant Treatment, Either With SSRIs or Duals at 8 Weeks and 6 Months
• Patient Tolerability Study of GSK163090
• Hypericum vs Fluoxetine for Mild to Moderate Adolescent Depression
• The Combination of Aripiprazole and Antidepressants in Psychotic Major Depression
• A 12-Week, Placebo Controlled Trial of Ziprasidone as Monotherapy for Major Depressive Disorder
• SA4503 8-Week Study in Major Depressive Disorder (MDD)
• Continuation Ketamine in Major Depression
• Study Evaluating Effexor® (Venlafaxine) in Achieving Response and Maintaining Remission
• Riluzole in the Treatment of Bipolar Depression
• Relative Bioavailability and Food Effect Study for GSK163090 in Healthy Male and Female Volunteers
• A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients
• Evaluating the Effectiveness of Escitalopram to Prevent Depression in Head and Neck Cancer Patients Receiving Treatment
• A Pilot Study Assessing EmSam in Bipolar Depression
• Study of Brain Response to Emotional Pictures Using a fMRI While on Duloxetine
• Phase IV:Safety and Efficacy of EMSAM in Adolescents With Major Depression
• An Open Trial of Duloxetine on Comorbid Major Depression and Chronic Headache
• An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder
• Open-Label Study of Duloxetine in the Treatment of Children and Adolescents With Major Depressive Disorder
• Do Antidepressants Induce Metabolic Syndromes METADAP Study
• Mood and Anti-craving Effects of Varenicline in Psychiatric Inpatients
• Study of Mood Effects of Varenicline (Chantix) in Depressed Outpatient Smokers
• An Investigation of the Sleep Architecture and Consequent Cognitive Changes in Olanzapine-Treated Depressed Patients
• Suicide Prevention by Lithium - the Lithium Intervention Study
• Does Dual Therapy Hasten Antidepressant Response?
• Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression
• Duloxetine for Perimenopausal Depression
• Omacor for Perimenopausal Depression
• Childhood Adversity, Genetic Polymorphisms and Stress in First Onset Major Depression
• The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression
• Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder
• Folate Augmentation of Treatment - Evaluation for Depression: a Randomised Controlled Trial
• A Study To Investigate Effects Of GSK561679 On Brain Activation During Emotional Processing In Healthy Volunteers
• Omega-3 Fatty Acids as Adjunct Treatment for Major Depressive Disorder
• 28-day Repeat Dose and Drug Interaction Study With Orvepitant (GW823296)
• Cimicoxib for the Treatment of Major Depression (SECIM)
• Maintenance Study for Adolescent Depression
• Investigating the Effectiveness of Telepsychiatry for Treating Major Depression in a Chinese American Nursing Home
• Duloxetine Versus Duloxetine Plus Non-Drug Therapy for Depression
• AZD6765 for Treatment Resistant Depression
• Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State
• Duloxetine Versus Paroxetine for Major Depression
• Escitalopram and Depression in Elderly Alzheimer's Patients
• GSK372475 Bioequivalence Study
• Adjunctive Ziprasidone in the Treatment of Bipolar I Depression
• Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
• Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)
• Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)
• Lilly's Emotional and Physical Symptoms of Depression Study (LEAPS)
• Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients
• Antidepressant Effects of NR2B in Major Depression
• Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive Disorder
• Brain GABA Levels and Treatment Response in Major Depressive Disorder
• A Study of Infliximab for Treatment Resistant Major Depression
• A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD)
• Functional Connectivity in Mood Regulating Circuit In Bipolar Depression and Mania
• Study Evaluating the Potential of DVS SR to Inhibit the CYP2D6 Pathway
• Study Evaluating DVS-233 for Treatment of Outpatients With Major Depressive Disorder
• Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism
• St. John's Wort And Kava In The Treatment Of Major Depressive Disorder With Comorbid Anxiety
• The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder
• Fluoxetine and Bupropion to Treat Patients With Depression and Alcoholism
• A Efficacy Study of PRX-00023 in Patients With Major Depressive Disorder
• A Study Of New Medicine (GSK 372475) For The Treatment Of Depression
• Safety and Antidepressant Effects of Rellidep in Major Depressive Disorder
• Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDD
• Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder
• Study Evalutating the Pharmacokinetics (PK) and Safety of a Single Dose of Desvenlafaxine Sustained Release (DVS SR)
• A Study To Evaluate The Effect Of WELLBUTRIN XL On Intraocular Pressure
• Evaluation of Three Continuation Therapies After ECT Concerning Efficacy and Cognition in Severly Depressed Patients
• Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease
• Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy Males
• A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and Insomnia
• Efficacy and Safety of SR58611A co-Administered With Escitalopram in Adults With Major Depressive Disorder
• A Study Evaluating the Safety and Tolerability of Abrupt Discontinuation of Saredutant in Patients With Depression
• Paroxetine/Bupropion in Suicide Attempters/Ideators With Major Depression
• Prozac Treatment of Major Depression: Discontinuation Study
• To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones.
• Galantamine Augmentation of Escitalopram for Treatment of Depression
• Phase III/Seroquel SR Bipolar Depression Monotherapy - US
• A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression
• Open-label Ziprasidone Study for Psychosis Treatment in Adolescents
• Augmentation of the Antidepressant Action of Sertraline With Triiodothyronine (T3)and Reboxetine: Clinical Efficacy, Adverse Effects and Predictors of Response.
• MDD POC Study GSK372475 Subjects Depressive Disease
• A Study for Participants With Major Depression
• Escitalopram in Depressive Patients With Acute Coronary Artery Syndrome
• Research Study for Major Depressive Disorder: Investigation of Glutamate Medications
• An Eight-week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive Disorder
• Evaluation of the Effects of Duloxetine on Norepinephrine
• Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)
• Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder
• Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder
• D-cycloserine for Major Depressive Disorder
• Study for Evaluating Different Methods of Measuring Depression Treatment Response
• A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients
• Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women
• A Repeat Dose Pharmacokinetic Study Of Paroxetine CR Tablet In Healthy Chinese Subjects
• Single Dose Pharmacokinetic (PK) Study Of Paroxetine CR(12.5-37.5mg) In Healthy Chinese Subjects
• Dichotic Listening as a Predictor of Medication Response in Depression
• Use of Omega-3 Fatty Acids for Perinatal Depression
• A Double-blind Sham Controlled Trial of rTMS in Treatment Resistant Major Depression
• Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program
• Lithium Versus Paroxetine in Patients With Major Depression Who Have a Family History of Bipolar Disorder or Suicide
• Antidepressant Safety in Kids Study
• Efficacy and Safety Study of Seroquel SR in the Treatment of Major Depressive Disorder
• Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer
• Sedating Antidepressant Improves Driving Safety in Patients With Major Depressive Disorder
• Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder (SIRIUS)
• Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients
• Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) In The Treatment Of Major Depressive Disorder
• A Pilot Study of Citicoline add-on Therapy in Patients With Bipolar Disorder or Major Depressive Disorder and Amphetamine Abuse or Dependence
• Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant Medication
• Study of Sildenafil for Treatment of SSRI-Antidepressant Sexual Dysfunction in Women
• Preventing Depression Recurrence in Diabetes
• The Antidepressant Efficacy of the Anticholinergic Scopolamine
• Antidepressant Effects on cAMP Specific Phosphodiesterase (PDE4) in Depressed Patients
• STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse
• Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) Versus Placebo in Peri- and Postmenopausal Women
• Efficacy Study of Memantine Hydrochloride and Escitalopram for the Treatment of Co-Morbid Depression and Alcoholism.
• A Local Register Study For Major Depression Of Paroxetine Controlled Release
• A Study of Eszopiclone in Subjects With Insomnia Related to Major Depressive Disorder
• Imaging Predictors of Treatment Response in Depression
• Study Evaluating the Effects of DVS SR and Duloxetine on the Pharmacokinetics of Desipramine in Healthy Subjects
• A Preliminary Study of the Effectiveness and Tolerability of Aripiprazole in Bipolar Depression
• An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive Disorder
• Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major Depression
• Biological Markers of Response to Treatment in Major Depressive Disorder
• Duloxetine for Chronic Depression: a Double-blind Study
• RU-486 in the Treatment of Bipolar Depression
• An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive Disorder
• Antidepressant Prophylaxis for Interferon-Induced Depression: Efficacy of Paroxetine
• Fluvoxamine Maleate in the Treatment of Depression/Depressive State : A Post-marketing Clinical Study in Children and Adolescents
• Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
• Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder
• A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder
• Memantine Augmentation of Antidepressants
• PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients
• Functional Neuroimaging in Depression
• Effect of Brain Lesion Severity on Treatment Response in Late-Life Depression
• Naltrexone & SSRI in Alcoholics With Depression/PTSD
• Antidepressant Medication Plus Directly Observed Therapy for Improving Adherence to Antiretroviral Therapy
• A 24-52-week Study to Evaluate the Long-term Efficacy and Safety of Saredutant in Patients With Depression (MAGENTA)
• A Placebo Controlled Trial of the Dopamine D-2 Receptor Agonist Ropinirole in Treatment of 60 Patients With Refractory Bipolar Depression.
• Determining Optimal Continuation Treatment Duration for Depressed Children and Adolescents
• Pilot Study of Duloxetine in Psychological Resilience
• Exercise Training Versus Drug Therapy for Treating Depression in Older Adults
• Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan
• Acamprosate in Alcoholics With Comorbid Anxiety or Depression
• Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders
• Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in Combination With an Antidepressant in the Treatment of Major Depressive Disorders
• Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression
• Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo and Active Control in Major Depressive Disorder
• Desipramine for Improving Cellular Signaling and Decreasing Symptoms of Major Depression
• Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder
• An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Depression
• Nicotinic Receptor Augmentation of SSRI Antidepressants
• Trial of Citalopram for the Prevention of Depression
• Sexual Functioning Study With Antidepressants
• Omega-3 Fatty Acids in Adolescent Depression
• Memantine Augmentation of Lamotrigine Incomplete-Response in Bipolar Depression
• AndroGel in Men With Major Depression and Incomplete Response to Antidepressant Treatment
• Effectiveness of Antidepressant Treatment for Depression in People With Parkinson's Disease
• Exercise to Treat Depression in Individuals With Coronary Heart Disease
• Effect of Specific Anti-Toxoplasmatic Add-on Medication in Toxoplasma Gondii Seropositive Individuals With Schizophrenia or Major Depression
• Study Evaluating the Efficacy and Safety of Desvenlafaxine Tablets in Adult Outpatients With Major Depressive Disorder
• Memory Functioning and Antidepressant Treatment
• Treatment of Depression Following Multiple Brain Tests
• Dichotic Listening as a Predictor of Medication Response in Depression
• Are Two Antidepressants a Good Initial Treatment for Depression?
• A Pilot Study Assessing Duloxetine's Efficacy in Atypical Depression
• Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression
• Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake Inhibitors
• Mineralocorticoid Receptor in the Treatment of Severe Depression
• The Effectiveness of Idazoxan in Treating TRD
• Safety and Efficacy Study of Vilazodone and Discovering Genetic Markers Associated With Response in Patients With Major Depressive Disorder
• A Study of Omega-3 as an Augmentor of Antidepressant Treatment for Major Depression
• PET Neuroimaging of [11C]Mirtazapine
• Cellular Aging and Neurobiology of Depression Study
• Mifepristone Treatment for Patients With Non-psychotic Major Depressive Disorder Receiving Bilateral ECT
• Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression
• Ropinirole Controlled Release (CR) as an Adjunctive Agent in the Treatment of Major Depression
• Bupropion For Reducing High-Risk Behaviors in Depressed Men Who Have Sex With Men (MSM)
• Effectiveness Study of Vilazodone to Treat Depression and to Discover Genetic Markers Associated With Response
• Lamotrigine in Treatment Resistant Depression in Adolescents
• Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder
• Study Evaluating Desvenlafaxine Sustained-Release (DVS-SR) in Adult Outpatients With Major Depressive Disorder
• Lexapro in the Treatment of Patients With Postpartum Depression
• Aripiprazole Augmentation Therapy in Treatment-resistant Depression
• Bipolar II Depression: Lithium, SSRI, or the Combination
• Sertraline for the Prevention of Recurrent Postpartum Depression
• A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD)
• Olanzapine Augmentation Therapy in Treatment-resistant Depression: a Double-blind Placebo-controlled Trial
• Treatment Resistant Bipolar Depression
• Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group
• GW679769 In Fibromyalgia
• Randomized, Placebo-controlled Trial of an AMPAkine in Major Depressive Disorder
• Essential Fatty Acids for Major Depression
• An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
• The Role of Cytokine-Serotonin Interactions in Post-Stroke Depression
• Depression and Traumatic Brain Injury
• Venlafaxine Augmentation in Treatment Resistant Depression
• Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder
• Efficacy and Safety of SR58611A in Patients With Major Depressive Disorder
• A Fifty-two-week Study to Evaluate the Safety of Saredutant in Adult and Elderly Patients With Depression
• An Eight-Week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
• An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
• An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Depression
• Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From Depression
• Improving Sleep and Psychological Functioning in People With Depression and Insomnia
• CONCERTA® (Methylphenidate Hydrochloride) as add-on Therapy in the Treatment of Adult Major Depressive Disorder.
• Study Evaluating Bifeprunox in Bipolar Depression
• Magnetic Resonance Imaging Study of Geriatric Depression
• Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive Disorder
• Escitalopram Combination Comparison Study for Adult Patients With Major Depressive Disorder
• A Study of Omega-3 as a Treatment for Major Depression
• Medications for the Treatment of Dysthymic Disorder and Double Depression
• Wellbutrin XL, Major Depressive Disorder and Breast Cancer
• Treatment of Post-Traumatic Brain Injury (TBI) Depression
• Investigation of a Combination Treatment of Escitalopram and rTMS
• Treatment of Comorbid Depression and Substance Abuse in Young People
• Study Of Indiplon/Placebo With Sertraline In Insomnia Co-Existing With Depression
• Effectiveness of Pramipexole for Treatment-Resistant Depression
• A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI's, and SNRI's Treatment in Major Depression With Anxiety
• Study of Medication and Placebo Response in Major Depression
• Estrogen and Perimenopausal Depression
• Study of Escitalopram Versus Placebo in the Treatment of Depressive Syndrome in Alzheimer's Disease, Vascular Dementia, and Mixed Vascular and Alzheimer's Dementia
• Effectiveness of Supplemental Calcium in Preventing Postpartum Depression
• Maintenance Interpersonal Psychotherapy for Sustaining Remission of Depression
• Comparing Various Treatments for Achieving and Maintaining Remission of Depression
• Estrogen for Treating Depression in Menopausal Women With Hot Flashes and Insomnia
• Integrated Treatment for Cocaine and Mood Disorders - 1
• Treatment of Mild and Subthreshold Depressive Disorders
• Natural Supplements for Unipolar Depression
• Safety Study of ORG 34517 for Major Depression With Psychotic Features
• Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.
• Study Evaluating Effexor XR for Major Depression.
• Study Evaluating Effexor XR in Elderly Patients With Major Depression.
• A Study To Investigate The Antidepressant Effect Of Lamotrigine In Patients With Bipolar Disorder Using Lithium
• Impact of Caregiver Depression on Asthma in the Child
• Pregnenolone Trial for Depression in Bipolar Disorders or Recurrent Major Depressive Disorder With Substance Abuse
• Depression: The Search for Treatment-Relevant Phenotypes-Pilot Study
• Can Additional Drug Therapy Accelerate Response Time to Antidepressants
• Abilify as an Adjunctive Treatment for Refractory Depression
• Efficacy of 18-Months of Antidepressive Medication Plus CBT or Dynamic or Supportive Psychotherapy for Recurrent Major Depression
• A Naturalistic Study of the Efficacy and Safety of Escitalopram in Treatment Resistant Depression
• Cognitive Therapy for Recurrent Depression
• Effects of Duloxetine vs. Escitalopram on Heart Rate Variability in Depression
• Modafinil for Atypical Depression
• Beyond Ageing Project: A Study for the Prevention of Depression
• A Study to Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845)
• Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder
• Depression-Diabetes Mechanisms: Urban African Americans
• Paroxetine for the Treatment of Interferon Related Side Effects for Hepatitis C
• Characterizing Psychological Consequences of Childhood Trauma
• Does Fluoxetine Have an Effect on the CNS CRF Systems in Women Abused in Childhood?
• Provigil in Conjunction With SSRIs for the Treatment of Mild or Moderate Depression With Attendant Symptoms of Sleepiness and Fatigue.
• Thyroid Medication and Antidepressants for Treating Major Depression
• Abilify Therapy for Reducing Comorbid Substance Abuse
• A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression
• Risperidone vs. Paroxetine for Panic Attacks
• Seroquel in Bipolar Depression Versus Lithium
• The Effects of Acute Administration of Bupropion on Neural Substrates Underlying Hedonic Capacity
• Open-Label Depakote ER in Patients With Bipolar I or II Depression and Alcohol Abuse or Dependence
• Use of Risperidone in ECT for Treatment Resistant Depression
• Carbamazepine Extended-Release for the Treatment of Bipolar Depression
• The Effect of Testosterone on Mood and Quality of Life
• Evaluation of Depression Symptoms and Brain Activity Associated With Response to Treatment of Depression
• Aripiprazole Treatment of Bipolar Depression
• Efficacy of Paroxetine in the Prevention of Depressive Syndrome in Patients With Chronic Hepatitis C Treated by PEG-Interferon Alfa Plus Ribavirin
• Treatment Choices for Improving Adherence and Outcome
• Switching to Duloxetine From Other Antidepressants
• A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain
• Duloxetine in the Treatment of Melancholic Depression
• Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine Trials
• Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response
• A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder
• A Neuroimaging Investigation of Brain Activity in Major Depressive Disorder and Bipolar Disorder
• Effect of the Menstrual Cycle on the Symptoms of Depression and Treatment Response
• Memantine to Reduce Neurocognitive Deficits Following Unilateral ECT for the Treatment of a Major Depression
• Treatment of Nicotine Dependence and Acute Depression
• Does Concurrent Hydrocortisone With Venlafaxine XR Speed Antidepressant Response?
• Depakote ER in Bipolar Depression
• Mifepristone in Refractory Depression
• Duloxetine for the Treatment of Dysthymia
• Memantine Treatment for Improving Rehabilitation Outcomes and Preventing Depression in Older Adults
• Brain Energy Metabolism in Individuals With Major Depressive Disorder Receiving Escitalopram
• Cognitive Therapy for Recurrent Depression
• Preventing Depression Relapse With Mindfulness-Based Cognitive Therapy
• Maintenance Treatment of Bipolar Depression
• Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders
• Bupropion SR for Major Depression and Depression NOS in Children and Adolescents With Bipolar Disorder
• Sertraline vs. Venlafaxine XR
• The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to Escitalopram
• Risperidone vs. Bupropion ER Augmentation of SSRIs in Treatment-Resistant Depression
• Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder
• Paroxetine and Interpersonal Psychotherapy for Maintaining Health and Well-being in Elderly Individuals With Depression
• Sleep Deprivation Plus Paroxetine for Treating Major Depression in Elderly Individuals
• Pharmacotherapy in Depression With Panic Spectrum
• Antidepressant Medication Plus Donepezil for Treating Late-life Depression
• Safety and Efficacy of Venlafaxine XR in Elderly Patients With Major Depression
• Sertraline for Preventing Post-stroke Depression and Improving Rehabilitation Outcomes
• Augmenting Antidepressant Treatment With Interpersonal Psychotherapy for Treating Late-life Depression
• Aripiprazole as Augmentation for TRD
• Treatment of Depression With Quetiapine
• Treatment of Major Depressive Disorder With Psychotic Features.
• The Neurobiology of Depressive Illness
• Risperidone and Suicidality in Major Depressive Disorder
• Efficacy and Safety of Escitalopram for Prevention of Depression Induced by Peg-Interferon in Hepatitis C Patients
• Depression, Epinephrine, and Platelet Function
• The Antidepressant Effects Of The NMDA Antagonist, CP-101,606, In Patients With MDD
• Antidepressant Maintenance in Traumatic Brain Injury
• Efficacy Study Measuring The Impact Of Treatment With Viagra On The Depressive Symptoms Of Men With Erectile Dysfunction
• Trial of Pindolol Augmentation in Venlafaxine Treated Patients With Major Depression
• Triiodothyronine (T3) Supplementation in the Treatment of Bipolar and Unipolar Depression.
• Cognitive Behavioral Therapy for Depression Relapse Prevention in Children and Adolescents
• Combined Interventions for Treating Depression and Chronic Back Pain
• Quantitative EEG (QEEG) as a Predictor of Treatment Outcome in Depression
• The Efficacy and Safety of Escitalopram for Depression in Multiple Sclerosis
• Hippocampal Volume in Young Patients With Major Depression Before and After Combined Antidepressive Therapy
• Magnetic Brain Stimulation for the Treatment of Adult Depression
• Combining Antidepressant Medication and Psychotherapy for Insomnia to Improve Depression Outcome
• Effectiveness of Fluoxetine in Young People for the Treatment of Major Depression and Marijuana Dependence
• Chronos: the Use of Chronobiological Treatment in Depression
• An International Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression
• Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder
• DECARD: Study of Escitalopram in the Prevention of Depression in Patients With Acute Coronary Syndrome
• Escitalopram for the Prevention of PEGASYS-associated Depression in Hepatitis C Virus-infected Patients
• Study Of 323U66 SR In Major Depressive Disorder
• Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder
• Free Venlafaxine Treatment for Marijuana Addiction and Depression - 1
• A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression
• Treatment of Depression in the Elderly
• An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression
• A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression
• The Effects of Wellbutrin (Bupropion) on Residual and Cognitive Symptoms in SSRI-treated Depression
• Metyrapone as Additive Treatment in Major Depression
• Fish Oil for the Treatment of Depression in Patients With Multiple Sclerosis
• Seroquel in Bipolar Depression Versus SSRI
• Stepped Care for Depression and Musculoskeletal Pain
• Cognitive Therapy for Recurrent Depression
• Omega-3 Fatty Acids to Improve Depression and Reduce Cardiovascular Risk Factors
• Org 24448 to Treat Major Depression
• Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder
• Study of Escitalopram in Adult Patients With Major Depressive Disorder
• VISN 20: Prophylactic Treatment of Interferon-Induced Depression in Hepatitis C Patients
• The Safety and Efficacy of Escitalopram in Pediatric Patients With Major Depressive Disorder
• Hormone and Sleep Response to Antidepressant Treatment in Adolescents and Adults With Depression
• Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder
• A Study of Aripiprazole in Patients With Major Depressive Disorder
• Study Of GW679769 In Major Depressive Disorder
• Safety and Effectiveness of S-adenosyl-l-methionine (SAMe) for the Treatment of Major Depression
• Ethyl Eicosapentanoic Acid (Ethyl-EPA) for Treating Major Depression
• A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
• A Study of Adjunctive Aripiprazole in Patients With Major Depressive Disorder
• A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder
• Study Comparing Adjunctive Risperidone Versus Placebo in Major Depressive Disorder That Is Not Responding to Standard Therapy
• Optimizing the Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) in Treatment-Resistant Depression
• Major Depressive Disorder In The Elderly
• Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive Disorder
• Effectiveness of Depression Treatment Following Coronary Artery Bypass Surgery
• Study Evaluating DVS-233 SR And Venlafaxine ER In Adult Outpatients With Major Depressive Disorder
• Rapid Antidepressant Effects of Ketamine in Major Depression
• Study Evaluating DVS-233 SR and Venlafaxine ER in Adult Outpatients With Major Depressive Disorder
• Lexapro and Pramipexole and to Treat Major Depression
• Depression in Alzheimer's Disease-2
• Rapid Antidepressant Effects of Yohimbine in Major Depression
• Antidepressant Medication Treatment for Depression in Individuals With Chronic Heart Failure
• Medication Treatment for Depression in Nursing Home Residents
• Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder
• Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder
• Treatment of Depression in Adults
• Duloxetine Compared to Escitalopram and Placebo in the Treatment of Patients With Depression
• A 6 Week Study to Determine the Effectiveness of R228060 in Adult Subjects With Major Depressive Disorder
• Study Evaluating DVS-233 SR In Adult Outpatients With Major Depressive Disorder
• Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial
• Duloxetine vs. Active Comparator in the Treatment of Patients With Depression
• Preventing Post-Stroke Depression
• SAM-e for the Treatment of Depression in Patients With Parkinson's Disease
• An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907, in Combination With Citalopram in Treatment Resistant Depression
• Adderall XR Compared With Concerta in Treating Young Cancer Patients With Memory, Attention, and Depression
• Seasonal Affective Depression (SAD) Study
• Duloxetine vs. Active Comparator for the Treatment of Depression
• Depression Study In Elderly Patients
• PUFA Augmentation in Treatment of Major Depression
• Sertraline Compared With Hypericum Perforatum (St.John's Wort) in Treating Depression
• Lethargic Depression Study
• Study Evaluating DVS-233 in Adult Outpatients With Major Depressive Disorder
• Treatment of Depression in Parkinson's Disease Trial
• Study of Duloxetine in Elderly Patients With Major Depressive Disorder
• Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression
• Clinical Trial of Estrogen for Postpartum Depression
• Improving Retention of Hispanics Receiving Antidepressant Therapy
• Prevention of Recurrence in Depression With Drugs and CT
• Research Evaluating the Value of Augmenting Medication With Psychotherapy
• An 8 Week Depression Study In Adults Diagnosed With Major Depressive Disorder
• An 8 Week Study Of Adults Diagnosed With Major Depressive Disorder
• An 8 Week Study Of Depression In Adults Diagnosed With Major Depressive Disorder
• Study of Pharmacotherapy of Psychotic Depression
• Cholinergic Modulation of Condition and Emotion in Mood Disorders: Functional Neuroimaging Studies
• Effects Of Antidepressants On Sexual Functioning In Adults
• Effects of Antidepressants on Sexual Functioning
• Major Depressive Disorder Study In Adults
• Drug Therapy to Treat Minor Depression
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED)
• Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED)
• A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder
• Study Evaluating Venlafaxine ER in Recurrent Depression
• Optimizing Electroconvulsive Therapy for Depression
• Treatment Outcome of Vascular Depression
• Magnetic Stimulation Therapy for Treating Vascular Depression
• A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression
• Treatments for Depression: Drug Versus Psychotherapy
• Dose Escalation, Double-Blind Treatment With Duloxetine Hydrochloride Once Daily Dosing for Evaluation of Safety in Major Depression
• Open-Label Treatment With Duloxetine Hydrochloride Once-Daily Dosing for Evaluation of Stabilization Dose in Patients With Major Depression
• Examination of a Soy-Based Supplement for Major Depression
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-073)
• Clinical Trial of Memantine for Major Depression
• Subject Information and Consent Form F1J-US-HMCB Duloxetine Once-Daily Dosing Versus Placebo in Patients With Major Depression and Pain
• Duloxetine Versus Placebo in the Prevention of Relapse of Major Depressive Disorder
• The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-061)
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-060)(COMPLETED)
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED)
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059)
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-066)(COMPLETED)
• Treatment of Patients With Major Depressive Disorder With MK0869 (0869-063)
• Olanzapine Versus Active Comparator in the Treatment of Depression in Patients With Schizophrenia
• Clinical Trial of Felbamate for Treatment-Resistant Bipolar Depression
• Raloxifene and Rimostil for Perimenopause-Related Depression
• Depression and Health Outcomes in Refractory Epilepsy
• Riluzole to Treat Major Depression
• Sequenced Treatment Alternatives to Relieve Depression (STAR*D)
• Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)
• Treating Alcohol Use In Older Adults With Depression
• Biological Aspects of Depression and Antidepressant Drugs
• Fluoxetine as a Quit Smoking Aid for Depression-Prone Smokers
• Clinical Trial of Fluoxetine in Anxiety and Depression in Children, and Associated Brain Changes
• The Depression in Alzheimer's Disease Study (DIADS)
• Treatment for Adolescents With Depression Study (TADS)
• Bone Loss in Premenopausal Women With Depression
• Treatment of Depression in Youth With Bipolar Disorders
• Treatment of Major Depression With St. John's Wort (Hypericum)
• Sertraline for Alcohol Dependence and Depression
• Treatment of Mid-Life-Related Mood Disorders
• Acute Effectiveness of Additional Drugs to the Standard Treatment of Depression
• Omega-3 Fatty Acids in the Treatment of Bipolar Disorder: A Double-Blind, Placebo-Controlled Trial
• Antidepressant Treatment of AIDS Related Depression.
• Antidepressant Treatment of Melancholia in Late Life
• Preventing the Return of Depression in Elderly Patients
• Cognitive and Drug Therapy for Drug-Resistant Depression
• Continuation Electroconvulsive Therapy Vs Medication to Prevent Relapses in Patients With Major Depressive Disorder